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Abstract 
 
In the present study, the aqueous and methanolic extracts of Dobera glabra 
leaves and Capparis decidua stems (two Sudanese medicinal plants), were 
screened for their hepatoprotective activity against CCl4 –induced 
hepatotoxicity in rats. These plants are used in traditional system medicine in 
the treatment of jaundice; no systematic studies on their hepatoprotective 
activity have been reported before.  
The hepatotoxicity produced by administration of CCl4 in paraffin oil 1:9 at a 
dose of 0.2 ml/kg for 10 days, was found to be inhibited by simultaneous oral 
administration of aqueous and methanolic extracts of C. decidua stems and at a 
dose of 200 and 400 mg/kg for 10 days, with evidence of decreased level of 
serum aspartate amino transferase, alanine amino transferase, alkaline 
phosphatase and bilirubin. 
In addition the concurrent administration of both extracts with CCl4 for 10 days 
masked the liver fatty changes induced by the hepatotoxic compound observed 
in the control rats and comparable with the hepatoprotective effect of the 
standard drug silymarin. 
The aqueous and methanolic extracts of Dobera glabra leaves in two doses, 
did not affect either the elevated level of the hepatic enzymes induced by CCl4 
or protectively from liver. 
Furthermore, the subchronic toxicological investigations were done to evaluate 
the adverse toxic signs and effects of the plant that possess hepatoprotective 
activity.  
A preliminary phytochemical screening of the powdered plants was also 
carried out.    
 
  ﻣﻠﺨﺺ اﻷﻃﺮوﺣﺔ
 
ﻩ اﻷﻃﺮوﺣﺔ ﺗﻤﺖ دراﺳﺔ اﻷﺛﺮ اﻟﻮاﻗﻰ ﻟﻠﻜﺒﺪ ﻟﻠﻤﺴﺘﺨﻠﺺ اﻟﻤﺎﺋﻰ واﻟﻤﻴﺜﻴﻠﻰ ﻹﺛﻨﻴﻦ ﻣﻦ اﻟﻨﺒﺎﺗﺎت ﻓﻰ هﺬ
اﻟﺴﻮداﻧﻴﺔ اﻟﺘﻰ ﺗﺴﺘﻌﻤﻞ ﺷﻌﺒﻴﺎ ﻟﻌﻼج اﻟﻴﺮﻗﺎن ﻓﻰ اﻟﺴﻮدان وهﻰ أوراق ﻧﺒﺎت اﻟﻤﻴﻜﺢ وﺳﻴﻘﺎن ﻧﺒﺎت اﻟﻄﻨﺪب 
ﺔ اﻷﺛﺮ  اﻟﻮاﻗﻰ ﻋﻠﻰ ﻟﻢ ﺗﺘﻢ دراﺳ.  اﻟﺒﻴﻀﺎء ﻣﻌﻄﻮﺑﺔ اﻟﻜﺒﺪ ﺑﻮاﺳﻄﺔ ﻣﺎدة راﺑﻊ آﻠﻮرﻳﺪ اﻟﻜﺮﺑﻮن ﻓﻰ اﻟﺠﺮزان
  . اﻟﻜﺒﺪ ﻟﻬﺬﻳﻦ اﻟﻨﺒﺎﺗﻴﻦ ﻣﻦ ﻗﺒﻞ
  
آﺠﻢ /  ﻣﺠﻢ 002ﺗﻢ إﺛﺒﺎت اﻷﺛﺮ اﻟﻮاﻗﻰ ﻟﻠﻜﺒﺪ ﻟﻠﻤﺴﺘﺨﻠﺺ اﻟﻤﺎﺋﻰ و اﻟﻤﻴﺜﻴﻠﻰ ﻟﺴﻴﻘﺎن ﻧﺒﺎت اﻟﻄﻨﺪب ﺑﺠﺮﻋﺔ 
 أﻳﺎم ﻓﻰ اﻟﺠﺮزان ﻣﻌﻄﻮﺑﺔ اﻟﻜﺒﺪ ﺑﻤﺎدة راﺑﻊ آﻠﻮرﻳﺪ اﻟﻜﺮﺑﻮن اﻟﻤﺬاب  01آﺠﻢ ﻳﻮﻣﻴﺎ ﻟﻤﺪة /  ﻣﺠﻢ 004و 
 أﻳﺎم ، ﺣﻴﺚ أﻧﻪ أﺣﺪث اﻧﺨﻔﺎﺿﺎ ﻣﻠﺤﻮﻇﺎ 01آﺠﻢ ﻳﻮﻣﻴﺎ ﻟﻤﺪة /  ﻣﻞ2.0ﺑﺠﺮﻋﺔ ( 9:1)ﻓﻰ زﻳﺖ اﻟﺒﺮاﻓﻴﻦ 
ﻓﻰ إﻧﺰﻳﻤﺎت اﻟﻜﺒﺪ واﻟﺒﻠﻴﺮوﺑﻴﻦ وﻗﻠﻞ ﻣﻦ اﻟﺘﻐﻴﺮات اﻟﺪهﻨﻴﺔ واﻟﻨﺴﻴﺠﻴﺔ ﻓﻰ ﺧﻼﻳﺎ اﻟﻜﺒﺪ ﻋﻨﺪ ﻓﺤﺼﻬﺎ ﻣﺠﻬﺮﻳﺎ  
  .وذﻟﻚ ﺑﺎﻟﻤﻘﺎرﻧﺔ ﻣﻊ اﻟﻤﺠﻤﻮﻋﺔ اﻟﺘﻰ أﻋﻄﻴﺖ ﻋﻘﺎر اﻟﺴﻠﻴﻤﺎرﻳﻦ اﻟﻤﺜﺒﺖ أﺛﺮﻩ اﻟﻮاﻗﻰ ﻟﻠﻜﺒﺪ
  
/  ﻣﺠﻢ 004آﺠﻢ و /  ﻣﺠﻢ 002إﻋﻄﺎء اﻟﻤﺴﺘﺨﻠﺺ اﻟﻤﺎﺋﻰ واﻟﻤﻴﺜﻴﻠﻰ ﻣﻦ أوراق  ﻧﺒﺎت اﻟﻤﻴﻜﺢ ﺑﺠﺮﻋﺔ 
( 9:1) أﻳﺎم ﻟﻠﺠﺮزان ﻣﻌﻄﻮﺑﺔ اﻟﻜﺒﺪ ﺑﻤﺎدة راﺑﻊ آﻠﻮرﻳﺪ اﻟﻜﺮﺑﻮن اﻟﻤﺬاب ﻓﻰ زﻳﺖ اﻟﺒﺮاﻓﻴﻦ 01آﺠﻢ ﻟﻤﺪة 
ﻠﻴﺮوﺑﻴﻦ وﻟﻢ ﻳﻘﻠﻞ  أﻳﺎم ﻟﻢ ﻳﺤﺪث أى اﻧﺨﻔﺎض ﻓﻰ ٍإﻧﺰﻳﻤﺎت اﻟﻜﺒﺪ واﻟﺒ01آﺠﻢ ﻳﻮﻣﻴﺎ ﻟﻤﺪة /  ﻣﻞ2.0ﺑﺠﺮﻋﺔ 
 وذﻟﻚ ﺑﺎﻟﻤﻘﺎرﻧﺔ ﻣﻊ اﻟﻤﺠﻤﻮﻋﺔ اﻟﺘﻰ أﻋﻄﻴﺖ راﺑﻊ آﻠﻮرﻳﺪ اﻟﻜﺮﺑﻮن  ﻣﻦ اﻟﺘﻐﻴﺮات اﻟﺪهﻨﻴﺔ ﻓﻰ ﺧﻼﻳﺎ اﻟﻜﺒﺪ
  .واﻟﻤﺠﻤﻮﻋﺔ اﻟﺘﻰ أﻋﻄﻴﺖ ﻋﻘﺎر اﻟﺴﻠﻴﻤﺎرﻳﻦ اﻟﻤﺜﺒﺖ أﺛﺮﻩ اﻟﻮاﻗﻰ ﻟﻠﻜﺒﺪ
  
ﻬﺮ أﺛﺮًا واﻗﻴًﺎ أﻳﻀﺎ  ﺗﻤﺖ دراﺳﺔ اﻷﺛﺮ اﻟﺴﻤﻰ  ﻟﻠﻤﺴﺘﺨﻠﺺ اﻟﻤﺎﺋﻰ واﻟﻤﻴﺜﻴﻠﻰ ﻟﺴﻴﻘﺎن ﻧﺒﺎت اﻟﻄﻨﺪب اﻟﺬى أﻇ
  .،آﻤﺎ ﺗﻤﺖ دراﺳﺔ آﻴﻤﻴﺎﺋﻴﺔ ﻣﺒﺪﺋﻴﺔ  ﻟﻨﺒﺎﺗﻰ اﻟﻤﻴﻜﺢ واﻟﻄﻨﺪب. ﻟﻠﻜﺒﺪ
  
 
Introduction 
 
 
Folk medicine is the mother of all other systems of medicine and even modern 
medicine. The knowledge about certain herbs, which have curative and 
palliative effects on disease conditions, has been transmitted from one 
generation to another by experienced elders and also by tribal herbal 
specialists. Sudan with its uniquely variable climatic conditions possesses a 
huge wealth of flora, cultivated or wild. These found their way to folk 
medicine and are used widely and effectively for the treatment of various 
human and animal aliments, especially by natives in rural areas. 
Many of these medicinal plants were extracted and used successfully in 
treatment of jaundice and different liver disorders, but in most cases their 
effectiveness has never been evaluated nor received any comprehensive 
scientific evaluation. Little information is documented with reference to their 
other pharmacological effects. 
The present study is an attempt to evaluate scientifically and through 
experimental manipulations the hepatoprotective activity of some Sudanese 
plants widely reputed to be effective.                                                                
 
Objectives: 
The aim of this study is to confirm or refute on scientific basis the folkloric 
uses of some selected Sudanese medicinal plants in the therapy of jaundice, an 
ubiquitous aliments, via:-  
• Assessment of the efficacy of Dobera glabra leaves and Capparis decidua 
stems using different extracts (aqueous and methanol) to prevent or 
alleviate CCl4 hepatotoxicity in Wister albino rats comparable with a 
reference drug silymarin. 
• Evaluation of their effects on haematological parameters and liver enzymes, 
i.e. alanine amino transeferase (ALT), aspartate amino transferase (AST), 
alkaline phosphatase (ALP) as well as bilirubin concentration. 
• Study of the histopathological changes in liver and other organs. 
• Determination of the toxicity potential of the plant that possess 
hepatoprotective activity. 
• Determination of the general phytochemical profile of these plants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Literature Review 
 
The liver, the largest gland in the body, plays a central role in the metabolism 
and excretion of endogenous and exogenous solutes .Because of its location 
between the digestive tract and the general circulation and its ability to extract 
a wide variety of compounds efficiently, the liver is ideally suited to remove 
solutes absorbed from the intestine (Cornelius, 1993). 
Primary diseases of the liver seldom occur except as a result of poisonings. 
Secondary hepatic disease, arising as part of generalized disease processes or 
by spreading from another organ, occurs more commonly. 
 
1.1. Diffuse and focal hepatic diseases:- 
Diffuse diseases of the liver can be classified as hepatitis (inflammatory 
disease), and hepatosis (non inflammatory condition), according to the 
pathological changes which occur, and the classification also corresponds 
roughly with the type of causative agent. Local suppurative infections of the 
liver do not cause clinical signs of hepatic dysfunction unless they are 
particularly massive or extensively metastatic. 
 
1.2. Hepatic dysfunction: 
The major hepatic functions which, when disordered, become responsible for 
clinical signs include: 
• Maintenance of normal blood glucose levels by providing the 
source as glycogen. 
• Formation of the plasma proteins. 
• Formation and excretion of bile salts and excretion of bile 
pigments. 
• Formation of coagulation factors. 
• Detoxification and excretion of many toxic substance including 
photodynamic agents (Radostitis et al, 2000). 
 
1.3. Clinical signs of liver disorder: 
1.3.1. Jaundice: 
Jaundice refers to the staining of tissue with bilirubin or bilirubin complexes. It 
is detectable when the plasma bilirubin exceeds 50m mol/L (3 mg/dl) 
(Finlayson et al, 1999). The staining is much more pronounced with 
conjugated bilirubin (direct), than with unconjugated bilirubin. (Radostitis et 
al, 2000) 
The usual divisions of jaundice are: 
• Haemolytic jaundice (pre hepatic) – increased 
bilirubin load for the liver cells. 
• Hepatocellular jaundice (hepatic or toxic) – defects in 
conjugation. 
• Cholestatic jaundice (obstructive or post hepatic), 
including hepatocellular (parenchymal) liver disease 
and large duct obstruction (Clark and Kumar, 2001).     
 
1.3.1.1. Haemolytic jaundice: 
The increased breakdown of red cells leads to an increase in production of 
bilirubin. The causes of haemolytic jaundice are those of haemolytic anaemia, 
e.g bacterial toxins, invasion of erythrocytes by protozoa or viruses, inorganic 
and organic poisons and immunological reactions (Radostitis et al, 2000). 
The clinical features that may be seen are anaemia, jaundice, splenomegaly, 
gallstones and leg ulcers. The level of unconjugated bilirubin is raised but the 
serum alkaline phosphatase, transaminase and albumin are normal (Clark and 
Kumar, 2001). There is no bilirubinuria because the hyperbilirubnaemia is 
dominantly unconjugated (Finlayson et al, 1999). 
 
1.3.1.2. Hepatocellular jaundice: 
Hepatocellular jaundice results from inability of the liver to transport bilirubin 
into the bile as a result of liver cell damage (Finlayson et al, 1999). The cause 
may be any of those diffuse diseases of the liver which cause degeneration of 
hepatic cells (hepatitis). Serum levels of total bilirubin are increased because of 
retention of direct bilirubin which also passes out in the urine, causing an 
elevation of urine levels, and the urobilinogen levels in the urine also rise 
(Radostitis et al, 2000). 
 
1.3.1.3. Cholestatic jaundice: 
Cholestasis is a failure of bile flow (Finlayson et al, 1999). This can be divided 
into extrahepatic and intrahepatic cholestasis. Extrahepatic cholestasis is due to 
large duct obstruction of the bile flow at any point in the biliary tract distal to 
the bile canaliculi. Intrahepatic cholestasis occurs owing to failure of bile 
secretion. Clinically in both types there is jaundice with pale stools and dark 
urine, and the serum bilirubin is conjugated (Clark and Kumar, 2001). 
 
1.3.2. Nervous signs (hepatic encephalopathy): 
Nervous signs include hyperexcitability, convulsions, muscle tremor and 
weakness, dullness, compulsive walking, head pressing and the failure to 
respond to signals; in some cases mania. The biochemical and anatomical bases 
of these signs are not well understood but many factors including 
hypoglycemia and failure of normal hepatic detoxification of excess amino 
acids and ammonia, or of acetylcholine may be involved. 
1.3.3. Edema and emaciation: 
In liver failure there is a low anabolism of amino acid and protein which is 
manifested by tissue wasting and a fall of plasma protein causing edema as a 
result of lowering the osmotic pressure of the plasma. 
 
1.3.4. Diarrhea and constipation: 
Bile salts have laxative and disinfectant effects, so if they are low or absent in 
the alimentary tract due to (hepatitis, hepatic fibrosis and obstruction of biliary 
system), constipation punctuated by attacks of diarrhea may ensue. The faeces 
are pale in color with high fat contents (steatorrhea). 
 
1.3.5. Hemorrhagic diathesis: 
This occurs in sever diseases of the liver due to deficiency in prothrombin 
formation and retardation of the fat soluble vitamins production (vit K). 
 
1.3.6. Abdominal pain: 
Abdominal pain in liver diseases is caused by distension of the organ with 
increased tension and lesions of the capsule. 
 
1.4. Etiology:   
1.4.1. Toxic hepatitis: The common causes are organic poisons e.g. copper, 
phosphorus, inorganic poisons e.g. carbon tetrachloride, poisonous plants and 
weeds e.g. Senecio, trees and shrubs e.g. Lantana camara, fungi, algae and 
insects. 
1.4.2. Infectious hepatitis: includes viruses e.g. Rift Valley Fever, Bacteria 
e.g. chlamydia sp, clostridium novyi which cause infectious necrotic hepatitis 
and systemic mycosis (Fungi) e.g. histoplasmosis. 
1.4.3. Parasitic hepatitis: Include acute and chronic liver fluke infestation, 
migrating larvae of Ascaris sp and chronic shistosomosis. 
1.4.4. Nutritional hepatitis: Selenium and vitamin E deficiency are factors in 
dietary hepatic necrosis in pigs. 
1.4.5. Congestive hepatopathy: Increased pressure in the sinusoids of the liver 
causes anoxia and compression of surrounding hepatic parenchyma; congestive 
heart failure being the common cause that leads to centrilobular degeneration 
(Radostitis et al, 2000). 
 
1.5. Investigations of liver disorder:  
1.5.1. Haematological testes: Full haemograms are performed. Anaemia may 
be present in hepatic diseases. Macrocytosis and prikilocytosis are often seen.  
1.5.2. Serum biochemical testes:  
1.5.2.1. Bilirubin: In the serum, bilirubin is normally almost all unconjagated. 
In liver disease, increased serum bilirubin is usually accompanied by other 
abnormalities in liver biochemistry. 
1.5.2.2. Aminotransferases: These enzymes (often referred to as 
transaminases) are present in hepatocytes and leak into the blood with liver cell 
damage. Two enzymes are measured: 
1.5.2.2.1. Aspartate aminotransferase (AST), which was previously known 
as serum glutamic oxaloacetate (SCOT), is a mitochondrial enzyme and is also 
present in heart, muscle, kidney and brain. High levels are seen in hepatic 
necrosis, myocardial infection, muscle injury and congestive cardiac failure. 
1.5.2.2.2. Alanine aminotranseferase (ALT), which was previously known as 
serum glutamic pyruvic transaminase (SGPT), is a sytosol enzyme, more 
specific to the liver so that its rise only occurs with liver disease. 
1.5.2.3. Alkaline phosphatase (ALP): This is present in the canalicular and 
sinusoidal membranes of the liver, bone, intestine and placenta. It is raised in 
cholestasis from any cause, intrahepatic or extrahepatic disease (Clark and 
Kumar, 2001). 
 
1.6. Principles of treatment in diseases of the liver:- 
 In diffuse diseases of the liver no general treatment is satisfactory and the 
main course should be to remove the source of the damaging agent. Death may 
occur as a result of hypoglycemia, hence blood glucose levels must be 
maintained by oral or intravenous injections of glucose. Because of the danger 
of guanidine intoxication an adequate calcium intake should be ensured by oral 
or parenteral administration of calcium salts. Protein intake should be 
maintained at a high level, as incomplete metabolism of the protein may result 
in toxic effects particularly in the kidney. Amino acid mixtures, especially 
those containing methionine, are used with apparently good results. Diets high 
in carbohydrate calcium and protein of high biological value and a number of 
specific substances should be availed. Administration of lipotrophic factors e.g. 
choline and maintenance on a diet low in fat and protein may reduce the 
compressive effects of fibrous tissue contraction. Some localized diseases of 
the liver may require surgical or medical treatment depending upon the cause 
(Radostitis et al, 2000). 
 
1.7. Plants used in the treatment of liver and biliary tract diseases:- 
Except for the use of the appropriate vaccine for the treatment of hepatitis 
caused by viral infection, there are few effective cures for liver diseases. It is 
not surprising therefore that there has developed a considerable interest in the 
application of those numerous worldwide traditional plant remedies against 
various liver diseases. In recent years, in vivo and vitro tests models have been 
developed for the evaluation of plants for their antihepatotoxic activities. These 
systems measure the ability of the test plant extract to prevent or cure in rats or 
mice liver toxicity induced by various hepatotoxins. The latter include carbon 
tetrachloride (most commonly used) and D-glactosamine and peroxides.  
A number of drugs from plants are used for treating biliary disorders as 
cholagogues (promoting the flow of bile). Herbalists prescribe such drugs 
either singly or more commonly as mixtures. In Europe the most widely used 
plant hepatoprotective agent is silymarin, a purified extract from Silybum 
marianum. Silymarin is also used as a standard when testing other drugs 
(Evans, 2002). 
 
1.8. Standard drug (Silymarin): 
Silymarin is a polyphenolic flavonoid derived from fruits and seeds of milk 
thistle (Silybum marianum) which has been clinically used as an 
antihepatotoxic agent for many liver diseases. Silymarin exhibits strong 
antioxidant activity, in addition to anti-inflammatory, cytoprotective, and 
anticarcinogenic effects (Lin et al, 2004).  
As a bitter, the milk thistle has a long history but more recently it has become 
recognized in Germany and continental Europe as a most effective liver 
remedy, particularly in those forms of hepatitis affecting the liver parenchyma. 
From the leaves and fruits several flavonolignans have been isolated, which 
exert marked antihepatotoxic activity in preventing the galactosamine 
induction of cell lesions. One of the constituents, silybin, has shown activity 
regarding the polymerase A of hepatocytes, corresponding with a stimulation 
of protein synthesis in liver cells (Morazzoni and Bombardelli, 1995). 
Commercially, silymarin is available as the dried, purified and standardized 
mixture of compounds mainly silybin, silandrin, silychristin, 3- 
deoxysilychristin, silymonin and sildianin extracted from the fruits.  
 
1.9. Hepatoprotective plants: 
Handa et al, (1986) reported that about 170 phytoconstituents isolated from 
110 plants belonging to 55 families possess liver protective activity, and about 
600 commercial herbal formulations with claimed hepatoprotective activity are 
being marketed worldwide currently. 
A number of plant drugs have been reported to have hepatoprotective activity 
and are used in treating many liver disorders, such as an aqueous extract of the 
roots of Cochlospermum trnctorium which occurs in Senegal and other West 
African countries, that is used to treat liver complaints in man (Sera et al, 
1984). This plant was also found to be hepatoprotective experimentally on rats 
and rabbits.  
An aqueous extract of young shoots of Rosmarinus officinalis showed 
significant hepatoprotective properties when given as a pretreatment before 
carbon tetrachloride administration (Hoefler et al, 1987). 
Leaf extracts of either species of Crepis rueppellii and Anisotes trisculcus or 
equal parts of each in a mixture given to mice and rats at 200 mg/kg body 
weight showed significant hepatoprotective activity. Both species of plants are 
used in Yemen to treat liver disorders and gallstones (Fleurentin et al, 1986). 
The ethanolic extract of the whole plant of Wedelia calendullacea exhibited 
protective activity against carbon tetrachloride – induced liver injury in vivo in 
rats. And also increased bile flow (Sharma et al, 1989). 
Silymarin, a flavolignan from the seeds of Silybum marianum, showed 
significant hepatoprotective activity against p.berghei-induced hepatic damage 
in Pramoys natalensis, changes in lipoproteins –X, AST, ALT, ALP and 
bilirubin reduced by the administration of silymarin at different doses. 
Maximum activity was observed at an oral dose of 5 mg/kg bwt (Chander et al, 
1989). 
Paulova et al, (1990) studied the hepatoprotective effect of silymarin in liver 
damage experimentally produced by carbon tetrachloride in dogs. Sixteen dogs 
were divided into 4 groups: intact controls, CCl4- induced liver damage (0.35 
ml/kg bwt orally) administrated, CCl4- induced liver damage and silymarin 
treated (100 mg/kg twice daily per os for 4 days), and silymarin prophylaxis 
(twice daily for 4 days) before CCl4 administration. As judged by liver function 
tests and liver biopsy, silymarin had a slight curative effect but considerably 
greater prophylactic effect.  
Picroliv, an iridoid glucoside mixture from the root and rhizome of P.kurrooa 
(P.kurroa), showed dose-dependent protective activity on isolated hepatocytes 
against thioacetamide – induced hepatic damage in rats (Visen et al, 1991). It 
enhanced the percentage of viable hepatic cells. Picroliv also antagonized the 
changes in the enzemes glutamic oxaloacetic transaminase, glutamic pyruvic 
transaminase and alkaline phosphatase produced by thiocetamide both in the 
isolated hepatocyte suspension as well as in serum. It was found to be more 
potent than silymarin.  
An alcoholic extract of the whole plant of Boerhavia diffusa when given orally 
exhibited hepatoprotictive activity against experimentally induced carbon 
tetrachloride hepatotoxicity in rats and mice .The extract also produced an 
increase in normal bile flow in rats (Chandan et al, 1991). 
Serum levels of gultamate oxaloacetate transaminase, gultamate pyruvate 
transaminase, acid phosphatase and alkaline phosphatase were used to 
elucidate liver damage in rats (Chattopadhyay et al, 1992). The levels of these 
enzemes were evaluated after 24 hours of paracetamol treatment (2 g/kg p.o.). 
However, rats fed "neem" leaf extract at 1g/kg p.o for 5 days prior to the 
addition of paracetamol to their diet showed much lower serum levels than 
those recorded for rats fed paracetamol alone. The elevated levels of serum 
enzymes in rats treated with paracetamol alone were due to induced 
hepatocellular necrosis; the neem extract afforded protection from this 
paracetamol –induced liver damage. The A. indica leaf extract contains mainly 
6 flavanol – o - glucosides which could be responsible for this hepatoprotective 
activity. 
Rao et al, (1993) studied the hepatoprotective activity of Hepatogard, which 
consists of tablets composed of crude powders of Picrorhiza Kurra, 
Andrographis paniculata, phyllanthus amarus, Boerhavia indica, Azadirachta 
indica, Eclipta alba, Zingiber officinalis, Piper longum and Triphala 
(combination of powders from the fruit of three plants Terminalia belerica and 
phyllanthus emblica). In studies with rats, Hepatogard (650mg/kg) exhibited 
hepatoprotective activities, and reversed the biochemical and histopathological 
changes by CCl4. 
The antiinflammatory and hepatoprotective activities of Boussingaultia gracilis 
var. pseudobaselloides against carrageenan-induced paw oedema, and CCl4 
and D-galactosamine induced hepatotoxicity in rats were investigated by Lin et 
al, (1994). The water extracts of leaves, stems or flower buds of the plant 
significantly decreased the acute increase in blood serum levels of AST and 
ALT caused by CCl4 and D – galactosamine. Histopathological changes in the 
liver were improved by treatment with the plant extracts.   
The alcoholic extract (100 mg/kg p.o. for 7 days) of aerial parts of 
Scrophularia koelzii (collected from India) significantly protected the rat liver 
against thioacetamide-induced toxicity (Garg et al, 1994). The activity was 
localized in the chloroform fraction from which 4 iridoid glycosides 
(scropolioside A, Koelzioside, harpagoside and 6-o-(3"-o-p-methoxy-
cinnamoyl) – alpha - L -rhamnopyranopyranosyl cataalpol) were isolated. 
Scropolioside –A showed the greatest hepatoprotective activity which was 
comparable with that of the hepatoprotective drug silymarin.  
The aqueous extract of the aerial parts of Achilla Millefolium, seeds of 
Cichorium intybus and aerial parts of Capparis spinosa were investigated by 
Gadgoli and Mishra, (1995) for their hepatoprotective activity. Some extracts 
of these plants were screened for their ability to protect CCl4 and paracetamol 
intoxicated livers in rats. The total aqueous extracts of all of the three plants 
were found active. The aqueous extract of Capparis spinosa produced the 
highest anti-hepatooxic activity, whereas the methanolic extract of Cichorium 
intybus produce the lowest activity. 
Triterpine datura alone was isolated for the first time from Solanum arundo 
seeds. The compound (5-15 mg /kg i/p) proved it’s potency in reducing 
harmful effects or maintaining the hepatic physiological mechanisms in both 
acute and chronic liver damage induced by administration of CCl4 in rats 
(Grace and Saleh, 1996). 
The hepatoprotective effects of Ginkgo biloba extract were studied in rats with 
CCl4 –induced liver damage by Ozenirler et al, (1997). The extract (200 mg/kg 
p.o.) was given to rats for 10 days before administration of a single dose of 
CCl4 (2 ml /kg i.p.). Pretreatment with the extract reduced hepatic 
malondialdehyde concentration significantly in CCl4 – treated rats, but did not 
alter glutathione or hydroxyproline concentrations. Light and electron 
microscopic findings showed that the extract limited CCl4 – induced 
hepatocyte necrosis and atrophy.  
The powder and different extracts of whole plants of Sida cordifolia were 
tested for hepatoprotective properties against CCl4-, paracetamol. 
[acetaminophen]- and rifampicin-induced hepatotoxicities in rats. The 
methanolic, aqueous and total aqueous extracts showed significant 
antihepatotoxic activity comparable with that of silymarin (Rao and Mishra, 
1998). 
The effects of Mentha Longifolia crude ethanolic extract (F1) and it is 
fractions, rich in luteolin glycosides (F2), apigenin glycosides (F3) and 
phenolic acid (F4), were studied on CCl4 - induced liver injury in mice 
(Mimica et al, 1999). Pretreatment with M.longifiolia extracts significantly 
improved hepatic antioxidant status in mice which was most pronounced in the 
reduction of CCl4 – mediated lipid peroxidation.  
The alcoholic and aqueous extracts of the tuberous roots of Cyperus rotundus 
were screened for their hepatoprotective activity on albino rats. An oral dose of 
100 mg/kg of the alcoholic extracts significantly lowered the serum enzymes 
like GOT and GPT in rats intoxicated with CCl4, the effect being similar to that 
of silymarin 100 mg/kg (Metha et al, 1999). 
Ethanolic, benzene, ethyl acetate and butanol extracts of Cassia tora were 
evaluated for their hepatoprotective activity using CCl4 as the hepatotoxin by 
Upadhyay et al, (2000). The ethanolic extracts of Cassia tora and its butanol 
fraction had hepatoprotective activities. Whereas the benzene fraction was 
found to be inactive. 
Hepatoprotective activity of Emblica officinalis “EO” and chyavanaprash 
"CHY" extracts were studied using carbon tetrachloride CCl4 –induced liver 
injury in rats (Jose and Kuttan, 2000). EO and CHY extracts were found to 
inhibit the hepatotoxicity produced by acute and chronic CCl4 administratin as 
seen from the decreased levels of serum and liver lipid peroxides (LPO), ALT, 
and ALP. Chronic CCl4 administration was also found to produce liver fibrosis 
as seen from the increased levels of collagen – hydroxyproline and 
pathological analysis. EO and CHY extracts were found to reduce these 
elevated levels significantly, indicating that the extract could inhibit the 
induction of fibrosis in rats.  
AL-Qarawi et al, (2001) studied the hepatoprotective activity of water extracts 
of Glycyrrhiza glarba against CCl4-induced acute hepatotoxicity in rats. Pre-
and-post-treatment with liquorice extract showed a dose-dependant reduction 
of CCl4- induced elevated serum levels of enzyme activity with parallel 
increase in total protein and albumin levels, indicating the ability of the 
liquorice to preserve the normal functional status of the liver. 
Different extracts of the fruits of Luffa echinata were tested for their 
hepatoprotective activity against CCl4-induced hepatotoxicity in albino rats 
(Ahmed et al, 2001). The degree of protection was measured by using 
biochemical parameters like AST, ALT, ALP, total protein and total albumin. 
The petroleum ether, acetone and methanolic extracts showed a significant 
hepatoprotective activity comparable with those of silymarin.   
A crude ethanolic extract of the leaf of Aphanamixis polystachya showed a 
beneficial effect on toxic liver injury (Gole and Dasgupta, 2002). Its 
antihepatoxic activity was evaluated on CCl4-induced liver injury in rat model. 
The assessment of hepatoprotective activity was evaluated by measuring the 
activities of AST, ALT, ALP, ACP, LDH, serum total bilirbin and albumin and 
by liver histology. The study showed that the crude ethanolic extract from A. 
polystachya leaves provided protection against acute carbon tetrachloride –
induced liver damage.   
Different extracts of Apium graveolens and Croton oblongifolius were tested 
for their hepatoprotective activity against CCl4 –induced hepatotoxicity in 
albino rats. The methanolic extracts showed the most significant 
hepatoprotective activity comparable with the standard drug silymarin (Ahmed 
et al, 2002). Other extracts, namely, petroleum ether and acetone, also 
exhibited a potent activity.  
The juice of the fresh leaves of Kalanchoe pinnata pers –is used very 
effectively for the treatment of jaundice in folk medicine in Buundelkhand 
region of India. The Juice of the leaves and the ethanolic extract of the marc 
left after expressing the juice were studied in rats against CCl4 –induced 
hepatotoxicity by Yadav and Dixit, (2003). The test material was found 
effective as hepatoprotective as evidenced by in vitro, in vivo and 
histopathological studies. The juice was found to be more effective than the 
extract. 
Gomes et al, (2003) investigated the hepatoprotective efficacy of the butanol 
extract obtained from the aerial parts of Glycosmis arborea. Albino rats were 
prophylactically treated with the extract (i.p) for 3 week. At the end of 3rd 
weeks all the groups were injected with hepatotoxic agents. After 48 h of 
injection, blood was collected and livers were taken out. Different enzymes in 
serum were assayed together with histopathological study with liver. Glycosmis 
arborea extract was able to overcome the toxic effects of hepatotoxic agents in 
terms of lowering the levels of serum GPT, alkaline phosphatase and increased 
levels of SOD in serum; also necrosis of liver produced by carbon tetrachloride 
was reversed by the extract. 
 
1.10. The toxicity of carbon tetrachloride:- 
The intoxication of CCl4 can occur by inhalation, ingestion or skin absorption. 
Inhalation of carbon tetrachloride causes an immediate and acute depression of 
central nervous system, and ingestion of toxic doses may cause death within 
24h due to anaesthetic depression or severe pulmonary oedema after 3-7 days 
leading to complete liver and renal damage (Radostitis et al, 2000). Skin 
contact can lead to dermatitis through defattening action. 
The toxicity of carbon tetrachloride occurs as a result of fat dissolution that 
destroys the selective permeability of tissue membranes allowing the escape of 
certain essential substances such as pyridine nucleotide co-enzymes (Clarke et 
al, 1981).  
MacSween and Whaley, (1992) reported that the toxic effect of CCl4 on liver 
cells is attributable to its metabolism in the smooth endoplasmic reticulum by 
the cytochrome P450 system with the production of the highly reactive 
trichloromethyl radical (CCl3). This moiety reacts with the double bonds of the 
unsaturated fatty acids in the membrane of the smooth endoplasmic reticulum, 
producing chloroform and a lipid radical. The latter then reacts with oxygen to 
initiate the autocatalytic reaction which results in the destruction of the 
membrane system of the endoplasmic reticulum.  
Clinical signs in acute toxicity are loss of appetite, dullness, staggering gait, 
evidence of gastrointestinal disturbances, constipation and diarrhoea (Clarke et 
al, 1981). Progressive narcosis, convulsion, depressions, muscle weakness, 
jaundice and death have also been reported (Radostitis et al, 2000). The most 
important detrimental effect and that responsible for delayed deaths is a 
consequence of the toxic action of carbon tetrachloride on liver cells. Small 
amounts of carbon tetrachloride produce fatty degeneration, while large 
amounts cause centrilobular necrosis. Repeated administration of small 
amounts of CCl4 lead to cirrhosis of the liver (Clarke et al, 1981).  
Mandal et al, (1998) reported that CCl4 caused hepatocellular necrosis, severe 
anaemia, lukopenia, lymphocytopenia, eosinophilia and haemoglobinaemia, 
and altered plasma albumin and globulin concentrations.  
Massive fatty change, gross necrosis, broad infiltration of the lymphocytes and 
kupffer cells around the central vein and loss of cellular boundaries were 
observed in the liver of CCl4 intoxicated rats. These were accompanied by 
increases in serum GOT and GPT (Lu et al, 2000). 
Administration of CCl4-induced significant impairment in hepatic antioxidant 
status, decreasing the glutathione content and superoxide dismutase activity 
and stimulating lipid peroxidation (Mimica, et al, 1999). 
Injection of CCl4 significantly increased serum aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) 
activities and bilirubin level in rats, but liver glycogen and serum cholesterol 
levels were decreased (Mukherjee et al, 1997). 
 
1.11. Plants used in the present experiments:   
1.11.1. Dobera glabra: 
Dobera glabra belong to the family Salvadoraceae and locally known as Al 
meikah (ELGhazali et al, 2004).  
 
1.11.1.1. The family Salvadoraceae:   
The Salvadoraceae is a small family of trees and shrubs, containing about 11 
species in 3 genera. The family is native to arid, often saline, areas in Africa, 
Madagascar, Arabia, India and Asia. 
 
1.11.1.2. Synonyms:  
Tomex glabra. Schizocalyx coriaceus., Salvadora glabra., Dobera coriacea.,  
Dobera roxburghii (ELGhazali et al, 2004). 
 
 
 
1.11.1.3. Plant description: 
Small tree up to 6 cm high. Bark grey, smooth, branchlets, finely pubescent, 
green, leaves simple, opposite, ellipticor. Ovate 4-9 x 2-4 cm, fleshy, 
coriaceous, glaucous, petioles about 2mm long. Inflorescence axillary and 
terminal panicles, shorter than leaves up to 5 cm long. Flowers white, sepals 3-
5 lobed, petals 4-5 lobed, free stamens 4-5 ovary 1- celled, short style and 
capitate stigma. Fruit elliposid drupes about 2x1.5 cm high brown, rough, 
flowers Feb – March, fruits April – Sep (ELAmin, 1990).  Figure (1) and 
Figure (2).  
 
1.11.1.4. Distribution:  
A shrub that grows in dry areas, on saline, heavy, or calcareous loam soils and 
in rocky hillsides. It grows abundantly in dry and moist lowland areas 
(Kenyatta and Henderson, 2001). In the Sudan it is found in Northern Province, 
Kordofan, Darfur, Khartoum and Equatoria (ELAmin, 1990), Red sea and 
Dongola Provinces (Broun and Massey, 1929). 
 
1.11.1.5. Folkloric uses:  
Dobera glabra latex is applied in both eyes once daily for three days for 
ophthalmic problems (Swaleh, 1999). The flowers of D. glabra provide an 
essential oil used by Sudanese women as perfume (Heywood et al, 2001). The 
flowers and leaves are used to perfume water (Broun and Massey, 1929). 
 
1.11.1.6. Common uses: 
Dobera glabra is one such typical drought indicator. Production of new shoots, 
fruits, and seeds always grow during the dry season. D. glabra produces edible 
fruits and the seeds are considered a typical famine-food. Fruit contains two 
green cotyledons, which are consumed after cooking. Before consumption the 
cover of the fruit is removed and seeds are washed thoroughly with ash. 
Usually consumed mixed with other foodstuff like boiled maize. It has to be 
cooked for a long time (up to 24 hours), and it produces a bad smell. According 
to farmers interviewed, excessive consumption causes stomachaches and other 
intestinal problems (Kenyatta and Henderson, 2001). 
In Somalia it is mainly used as shade for the farmer and his livestock. A bush 
fallow is often used to maintain soil fertility (Leslie and Jarvis, 1991) and used 
as fodder (Barrow, 1991). In Kenya it used as a diet and fodder tree (Becker, 
1984).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1)    Dobera glabra tree 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
                                         
 
          
 
        
                                           
 
Fig. (2)      Dobera glabra leaves 
 
 
 
 
 
 
1.11.2. Capparis decidua: 
Capparis decidua belong to the family Capparaceae and locally known as Al 
Tundub (ELGhazali et al, 2004).   
 1.11.2.1. The family Capparaceae (Caper family): 
The Capparaceae is a medium-sized family related to Cruciferae, It comprises 
some 700 species, containing herbs, trees and shrubs in 50 genera which are 
found principally in tropical and warm temperate regions. Few of its members 
are of horticultural or economic importance; the best - known are the capers 
(Heywood et al, 2001).   
 
1.11.2.2. The Genus Capparis:   
The water extract of roots of Capparis micrantha is used as an antispasmodic, 
for tooth-ach and as taenifuge (EL Ghazali et al, 1987). Roots of Capparis 
sepiaria pounded with garlic and black pepper is mixed with hot water, about 
three teaspoons thrice a day are given for about 3 days to cure post delivery 
pains (Vijayakumar and Puliaiah, 1998).  
The common uses of Capparis spinosa are analgesic, anthelmintics, 
emmenagoque, aperient, tonic and diuretic. Root extract is used for cure of 
rheumatism and paralysis, and also for the treatment of enlarged spleen and 
tuberculous glands (Atiqur Rahman et al, 2004). 
Gadgoli and Mishra, (1995) reported that the aqueous extract of Capparis 
spinosa has a hepatoprotective activity when tested against CCl4 and 
paracetamol intoxicated liver in rats. Broun and Massey, (1929) reported that 
the root of Capparis tomentosa is stated to be poisonous to camels. The leaves 
of Capparis zeylanica is used as anti-inflammatory (Reddy et al, 1998). 
 
 
1.11.2.3. Synonyms:  
Sodada decidua forssk, Fl. Aegypt.- Arab. Capparis aphylla Hegne ex Roth. 
(ELGhazali et al, 1994).  
 
1.11.2.4. Capparis decidua description:- 
Armed much- branched shrubs or small trees up to 3m high. Bark smooth 
green turning whitish grey when old. Branches with stipular prickles up to 0.5 
cm long brown-yellowish. Petioles about 1mm long, glabrous, leafless except 
on young shoots. Inflorescence lateral and terminal fascides or corybose 
racemes. Flowers pink, about 2-2.5cm, 2-5cm. Pedicels about 1cm long. Sepals 
unequal, anterior outer sepals larger and deeply saccate, slightly imbricate or 
subvavate, gynophore 1-2cm long. Fruits globes, pointed, pink, 0.5-1.5cm 
across, edible, seeds many. Flowers Dec. - March, fruits march- may (ELAmin, 
1990). Figure.3. 
 
1.11.2.5. Distribution: 
Capparis decidua is widely distributed in typical of deserts and semi- deserts 
of northern and central Sudan especially on sandy soils and in low rainfall 
savanna on clays (ELAmin, 1990). It is also found in Blue Nile, Upper Nile, 
western and eastern Sudan besides northern areas of the country (Von Maydell, 
1986 & ELGhazali et al, 1987). In India it is a main distributed in western 
Rajasthan, Punjab, Gujarat, central areas and the Decean (Gupta et al, 1989).            
 
1.11.2.6. Common uses:  
 The fruits of C. decidua Edgew are known to be edible and it used as a 
vegetable or pickle. Its wood (which is resistant to white ant attack) is suitable 
for flour mill pivots and well foundations and branches for fencing (Gupta et 
al, 1989). It was found to be the best species for shelterbelts to check the 
movement of sand and Dune stabilization (Pandey and Rokad, 1992). 
 
1.11.2.7. Folkloric uses: 
Capparis decidua is anthelmintics, analgesic, aphrodisiac, carminative, 
diaphoretic, emmenagoque and laxative. The bark extract is used in asthma and 
cough. The pest of young leaves and branches are applied as plaster on boils 
and swelling (Atiqur Rahman et al, 2004), and diuretics, antigout, anti-
inflammatory, astringent, stomachic, laxative, antidote and used for skin 
diseases (ALYahya, 1986). The decoction of fresh twigs is kept for 2 – 3 days 
and then taken against jaundice, the fumigation of the stems are used as anti-
rumatic (ELGhazali et al, 1997). The water extract of the green stems is used 
as a bathe for jaundice (ELGhazali, 1986). The water extract of the stems is 
used against jaundice. The stems are used as a poultice for swelling and joint 
pains (ELGhazali et al, 1987) the poultices of the twigs are used against hed-
ache (ELGhazali et al, 1994).  A decoction prepared from the stem bark is used 
to treat diarrhoea. A decoction prepared from the roots is used to relieve fever 
and is also used for jaundice. As fumigation, roots are used to treat fever and 
rheumatism (ELKamali et al, 1999). The aerial part is used for rheumatism, 
gout; externally the infusion is used for boils, eruption and ulcers, while 
internally as antidote to poisons (Shah et al, 1989).  
 
1.11.2.8. Chemical constituents: 
The chromatographic separation of aerial parts of Capparis decidua, a woody 
medicinal plant, afforded one shikimate derivative, two acyclic terpenoids, four 
fatty acids, two sterols and two lupare triterpenoids (Abdel Mogib et al, 2000).   
The flowers and fruits contain a series of hydrocarbons, aliphatic alcohol and 
B- carotene. The seeds contain glucocapparin (Isothiocyanate glucoside), 
whereas the root barks contain isocodonocrine (spermidine alkaloid) 
(ELGhazali et al, 1994). The aerial part of C. decidua contains alkaloids, 
flavonoids, sterols (triterpenes), tanins, cardiac glycoside and saponins 
(ALYahya, 1986). 
Ahmed et al, (1992) isolated two new spermidine alkaloids, 14- N- 
acetylisocodomcarpine and 15-N- acetylcapparisine from the root bark of this 
medicinal species.  
Moreover, shoots and fruits of C.decidua were analysed for their ascorbic acid 
contents during the summer and winter seasons. The amount of ascorbic acid 
was greater in summer than in winter in all parts of C.decidua (Goswami et al, 
1994). 
Duhan et al, (1992) found that besides Fe, Zn, Ca and phosphorus, C.decidua 
contains appreciable amount of beta- carotene and vit C. 
 
1.11.2.9. Nutritional value of Capparis decidua: 
Capparis decidua has edible fruits rich in protein and minerals and a high 
seeds fat content. Many of plant parts have medicinal uses. The fruits, flowers 
and buds yielded 14%. Surface wax (w/w) was analyzed and found to consist 
of a mixture of compounds, mainly straight chain saturated hydrocarbons and 
ketones with C28 and C32 chain lengths, associated with N- and S- containing 
oils respectively. The seeds also contained 1.7% sugar and 8.6 proteins (Rai, 
1987). 
The unripe fruit of ker (C.decidua) contains 14.88 protein, 7.43 fat, 5.96 ash, 
12.32 crude fiber and 59.41% Dm digestible carbohydrates. Beta- carotene, 
ascorbic acid, calcium, phosphorus, iron, copper, zinc and manganese, were 
5.4, 120.7, 90.0, 179.0, 3.5, 1.1, 1.6, and 1.9 mg/100g respectively. Total 
protein fraction contained albumin (53%) globulin (16%), prolamine (11%) 
and glutelin (12%). Ker fruit had phytic acid, 304 mg/100g (Chauhan et al, 
1986).  
 1.11.2.10. Pharmacological studies: 
Antidiabetic treatment with powdered fruit of Capparis decidua decreased 
alloxan induced lipid peroxidation (LPO) significantly in erythrocytes, kidney 
and heart. Erythrocyte superoxide dismutase (SOD) activity decreased while 
the kidney and heart SOD increased in diabetic animals. These alterations in 
SOD were counteracted by insulin as well as with powdered fruit of C. 
decidua. Increased catalase (CAT) activity in erythrocytes, liver, kidney and 
heart with C. decidua treatment indicate that the treatment may neutralize H2O2 
toxicity by its increased decomposition by CAT. Result shows that treatment 
with C. decidua lowers alloxan induced LPO and alters SOD and CAT 
enzymes to reduce oxidative stress (Yadav et al, 1997). 
Ageel et al, (1986) reported that the ethanolic extract of Capparis decidua and 
aqueous extract of Capparis spinosa were found to possess significant anti- 
inflammatory activity against carrageenas induced odema in rats; these two 
plants were also tested for their antipyretic and analgesic activity. C.decidua 
was found to possess significant antipyretic effect. Both of them are devoid of 
analgesic activity. 
Allium sativum (A.s), Capparis decidua (C.d), Frankenia pulverulenta (F.p), 
Ricinus communis (R.c) and Trigonella foenum-graecum (T.fg) were tested for 
their diuretic activity by Tanira et al, (1989). Out of the five plants testd in this 
study, A.s and T.fg showed no effective diuretic action; C.d and R.c caused a 
fast but a short-lived increase in urine volume without causing a change in the 
electrolyte concentrations, while F.p caused a delayed increase in urine volume 
associated with an increase in both sodium and potassium concentrations.  
Moreover, C.decidua was shown to have a very high dietary fiber content that 
contributed to its pronounced hypocholesterolemic effect which appeared to 
operate through increased fecal excretion of cholesterol as well as bile acids. 
Dietary hemicellulose showed a significant positive correlation with fecal bile 
acids. The dietary fibred influenced total lipids, cholesterol, triglycerides and 
phospholipids of liver to varying extents (Agarwal and Chauhan, 1988). 
 
1.11.2.11. Toxicological studies: 
Ethanolic extract of Capparis decidua aerial parts had significant cytotoxic 
effects on mouse bone marrow cells, but had little effects on their chromosome 
structure (Shah et al, 1989).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Fig. (3)    Capparis decidua tree 
 
 
Materials and Methods 
 
2.1. Materials 
 
2.1.1. Plants: 
The experimental plants were the leaves of Dobera glabra and the stems of 
Capparis decidua. 
 
2.1.1.1. Collection and identification of the tested plants: 
2.1.1.1.1. Dobera glabra:    
Dobera glabra leaves were procured on April 2003 from trees growing in 
eastern south of Khartoum, and dried at room temperature. The plant was 
identified and authenticated by the botanists in Medicinal and Aromatic Plants 
Research Institute. 
 
2.1.1.1.2. Capparis decidua:  
Capparis decidua stems were collected from Arkaweit area in southern 
Khartoum, on May 2004, and dried at room temperature. The plant was 
authenticated by the botanists in Medicinal and Aromatic Plants Research 
Institute.  
 
2.1.2. Animals: 
All experiments were carried out with adult Wister albino rats (Poole, 1989) of 
either sex, weighing from 75-130 gm, supplied by the animal house of 
Medicinal and Aromatic Plants Research Institute were used.  They were 
housed under standard experimental condition in cages within the premises of 
Medicinal and Aromatic Plants Research Institute. They were given one week 
adaptation period with free access to diet and water.  
2.1.3. Instruments and chemicals: 
A wide range of instruments and chemicals were used during the course of this 
study as follow: 
2.1.3.1. Instruments: 
1. Soxhlet apparatus   Quick FIT, EX5/83. ENGLAND. 
2. Freeze drier   ALPHA – I-12 W. GERMANY.  
3. Rotavapor     BUCHI 011 SWITZERLAND  
4. Water bath     BUCHI 461 SWITZERLAND  
5. Sensitive balance    HF-300G  A&D COMPANY, Limited. 
6. Spectrophotometer JENWAY 6305 UV/Vis., JENWAY LTD, UK.  
7. Centrifuge     Hettich EBA35.werk-Nr, BAUJAHR.   
8. Water bath    fisher.    
9. Microhaematocrit reader  Hawksley, ENGLAND. 
10. Microhaematocrit centrifuged  Hawksley & son ltd., ENGLAND. 
11. Cristaseal  Hawksley, ENGLAND. 
12. Haemacytometer  Hawksley, ENGLAND. 
13. Counter  ENM- ENGLAND.  
14. Light microscope Olympus optical, CO. LTD, JAPAN. 
15. Rough balance  SARTORIUS 2351, GERMANY. 
16. Nasogastric tube (FEEDING TUBE) CH/FR (8) KAWAMOTO  
CORPORATION OSAKA JAPAN. 
17. Syringe 1ml/cc Neoject Neomedic Limited, Middlesex, UK. 
18. Syringe 5ml/cc CHUNJEE MEDICAL INDUSTRY CO. KORIA. 
19. Capillary tubes heparinized SUPE- RIOR- GERMANY. 
20. DESAGA CabUVIS, SARSTEDT, GERMANY. 
 
 
2.1.3.2. Chemicals: 
1. CCl4   (E. Merck, Darmstadt Art- 2222). 
2. Liquid paraffin B.P BELL.SONS&CO. (DRUGGSTS) LTD.   
ENGLAND.                    
3. Acacia mucilage. 
4. Silymarin Simepar – mepha.   
5. GOT- GPT – ALP-Bilirubin PLASMATEC LABOROTORY.  
           PRODUCTS LTD. BRIDPORT DT6 5BU.U.K.  
6. Sodium hydroxide BDH chemicals Ltd poole, ENGLAND. 
7. Drabken. (potassium cyanide 0.2g, potassium ferrocyanide 0.2g, sodium 
bicarbonate 1.08g, distilled water to 1 liter).  
8. Hayme's solution (consisting of sodium chloride 1.0 g; sodium sulphate 
5.0 g; mercuric chloride 0.5 g; distilled water 200 ml). 
9. Standard Hb  cromatest. 
10. Buffer formal saline 10%. 
11. EDTA. 
12. Halothane BP   ICI India Limited, Ennor, chennai- 600 057. 
13. Methanol AR   Analytical Rasayan.  
14. Ethanol Absolute   RIEDEL – DEHAEN AG SEELZE – HANNOVER. 
15. Chloroform AR Analytical Rasayan.  
16. Petroleum ether    E. Merck (India) Limited, Mumbai- 400 018. 
17. Sodium sulphate anhydrous  E. Merck, Darmstadt.                                                        
18. Acetic anhydride     BDH chemicals Ltd poole, ENGLAND. 
19. n- hexane    LOBA CHEMIE PVT. LTD. Mumbai- 400 002. INDIA. 
20. Picric acid BDH chemicals Ltd poole, ENGLAND. 
21. Potassium hydroxide Scharlau chemie S.A. La Jota, 86 08016- 
Barcelona, SPAIN. 
22. Hydrogen peroxide B.P.  BELL SONS&CO. LTD; ENGLAND.  
23. Benzene (benzol)   E. Merck, Darmstadt   Art.1783.               
24. Sodium chloride BDH Ltd  poole, ENGLAND. 
25. HCL BDH chemicals Ltd poole, ENGLAND  
26. Mercuric chloride BDH chemicals Ltd poole, ENGLAND. 
27. Potassium iodide Evans medical Ltd spcke, Liverpool.   
28. Mercuric iodide BDH chemicals Ltd poole, ENGLAND. 
29. Ferric chloride Anhydrous Laboratory chemicals. 
30. Ammonium hydroxide METLAB supplies LTD. 
31. Aluminum chloride BDH chemicals Ltd poole, ENGLAND. 
32. Vanillin BDH chemicals Ltd poole, ENGLAND. 
33. Sulphuric acid philip harris, ENGLAND.  
34. Silica gel BDH chemicals Ltd poole, ENGLAND. 
35. Mayer’s reagent: Containing: 
a) 1.36 g of Hgcl2 dissolved in 60 ml of distilled water. 
              b)  5 g potassium iodide in 10 ml distilled water. 
                   Solution a & b mixed and diluted to 100 ml with distilled water. 
      36. Valser’s reagent:   
         10 g of potassium iodide to 100 ml distilled water, add mercuric 
iodide until saturated. Excess mercuric iodide is removed.  
 
 
 
 
 
 
 
 
 
2.2. Methods 
 
In this class all experiments were divided into two main parts, the first part 
concerned with plants and the second part dealt with animals. 
 
2.2.1. Plants: 
Three experiments were performed in the tested plants material.  
2.2.1.1. Extraction methods: 
2.2.1.1.1. Aqueous extract: 
The coarse powder of each plants material were soaked in boiling distilled 
water and left for 2 hours at room temperature, the mixtures were filtered and 
the filtrates were cooled overnight at -4c° and concentrated, the concentrated 
extracts were freeze dried (Komolafe et al, 1988) The yields percentages were 
calculated and the residue obtained was kept in a refrigerator for future use. 
 
2.2.1.1.2. Methanolic extract:  
       (Continuous method extraction) 
A known weight of the coarsely powdered part of each plant was extracted 
successively with chloroform (60 -80 c°) and methanol (98%) using soxhlet 
extractor. The chloroform extract was kept a side and the methanolic extracts 
were filtered, evaporated, dryness using Rotavapor apparatus (under reduce 
pressure), and the yields were calculated. The residue obtained was kept in dry 
clean bottles till used (Harborne, 1973). 
 
2.2.1.2. Phytochemical screening: 
A general screening was carried out according to the method of (Harborne, 
1973) to determine the chemical constituents of each plants material. 
 
2.2.1.2.1. Preparation of the extract: 
10 g of the powdered tested part of the plants were refluxed with 100 ml of 
80% of ethanol four hours. The cool solution was filtered and enough 80% 
ethanol was passed through to complete volume of the filtrate to 100 ml. The 
prepared extract (PE) was used for the following tests. 
 
2.2.1.2.1.1. Test for Unsaturated Sterols and Triterpenses: 
10 ml of the PE was evaporated to dryness on a water path and the cooled 
residue was stirred several times with petroleum ether to remove most of the 
coloring  materials .The residue was then extracted with 20 ml chloroform 
solution was dehydrated over sodium sulphate anhydrous. 5 ml portion of the 
chloroform solution was mixed with 0.5 ml of acetic anhydride followed by 
2drops of conc. Sluphuric acid .The gradual appearance of green, blue  pink to 
purple color was taken as an evidence of the presence of sterols (green to blue) 
and or triterpenses  (pink to purple ) in the sample. 
 
2.2.1.2.1.2. Test of Alkaloids: 
7.5 ml of the PE was evaporated to dryness on a water bath   5% ml of 2N HCl 
was added and stirred while heating on the water bath for 10 minutes, cooled 
filtered and divided into two test tubes. To one test tube few drops of Mayer's 
reagent was added while to the other tube few drops of Valser's reagent was 
added. A slight turbidity or heavy precipitate in either of the two test tubes was 
taken as presumptive evidence for the presence of Alkaloids. 
 
2.2.1.2.1.3. Tests for Flavonoids: 
17.5 ml of the PE was evaporated to dryness on water path, cooled and the 
residue was defatted by several extractions with petroleum ether and the 
defatted residue was dissolved in 30 ml of 80% ethanol and filtered. 
The filtrate was used for following tests: 
A/  to 3ml of the filtrate in a test tube 1 ml of 1% aluminum chloride  solution 
was in methanol was added . Formation of a yellow color indicated the 
presence of Flavones or and chalcone. 
B/ to 3ml of the filtrate in a test tube 1ml of 1% potassium hydroxide solution 
was added.  A dark yellow color indicates the presence of Flavonoids 
compounds (flavone or flavonens) chalcone and or flavonols. 
 
2.2.1.2.1.4. Tests for Tannins: 
For this test 7ml quantity of the PE was evaporated to dryness on water bath 
.the residue was extracted several times with n-hexane and filtered. The 
insoluble residue was stirred with 10ml of hot saline solution .The mixture was 
cooled, filtered and the volume of the filtrate was adjusted to 10 ml with more 
saline solution. 5ml of this solution was treated with few drops of gelatin salt 
reagent Formation of immediately precipitate was taken was evidence for the 
presence of tannin in the plant sample. To another portion of this solution, few 
drops of ferric chloride test reagent were added. The formation of blue, black 
or green was taken as an evidence for the presence of tannins. 
 
 2.2.1.2.1.5. Test for Saponins: 
1g of the original dried powder plant material was placed in a clean test tube. 
10 ml of distilled water was added and the tube was stopped and vigorously 
shaken for about 30 seconds. The tube was then allowed to stand and observed 
for the formation of (honeycomb) the appearance of honey comb, which 
persisted for least an hour, was taken as evidence for presence of saponins. 
 
 
 
 2.2.1.2.1.6. Test for Cyanogenic glycoside: 
3g of the powdered plant sample was placed in erlenmeyer flask and sufficient 
water was added to moisten the sample, followed by 1ml of chloroform (to 
enhance every activity). A piece of freshly prepared sodium picrate paper was 
carefully inserted between a split crock which was used to stopper the flask, a 
change in color of the sodium picrate paper from yellow to various shades of 
red was taken as an indication of the presence of cyanogenic glycoside. 
 
 2.2.1.2.1.7. Test for Anthraquinone glycoside: 
1g of the powdered plant sample was boiled with 10ml of 0.5 N KOH 
containing 1ml of 3% hydrogen peroxide solution. The mixture was extracted 
by shaking with 10ml of benzene. 5ml of the benzene solution was shaken with 
3ml of 10% ammonium hydroxide solution and the two layers were allowed to 
separate .The presence of anthraquinones was indicated if the alkaline layer 
was found to have assumed pink or red color. 
 
 2.2.1.2.1.8. Test for Cumarins: 
1g of the original powdered plant sample boiled with 20ml distilled water in 
test tube and filter paper attached to the test tube to be saturated with the vapor 
after a spot of 0.5 N KoH put on it. Then the filter paper was inspected under 
UV light, the presence of cumarins was indicated if the spot have found to be 
adsorbed the UV light.   
      
2.2.1.3. Thin layer chromatography: 
2.2.1.3.1. Preparation of silica gel thin layer chromatography plate:  
30 gm of silica gel were shaken for 2 min with 60 ml distilled water in a 250 
ml stoppered conical flask. The slurry was spreaded using spreader making 
0.25 mm thick layer on 5 glass plate 20 x 20 cm. the coated plates were 
allowed to dry at room temperature then activated at 105 Cº for one hour. The 
hot plates were stored and allowed to cool.  
 
2.2.1.3.2. Stationary phase: 
The stationary phases used were:  
1- Silica gel type G.  
2- Pre coated plate silica gel (50 F  254 and 60 F 254).  
 
2.2.1.3.3. Mobile phase: 
Butanol      Water     Acetic   40 – 50 – 10 
Application of samples:  
The test sample to be separated was applied by means of capillary tubes. 
 
2.2.1.3.4. Preparation of locating reagents:  
The following locating reagent was used: 
Vanillin – sulphuric acid. 
1gm vanillin was dissolved in 100 ml concentrated sulphuric acid (Tyihak et 
al, 1963). 
 
2.2.2. Animals: 
This part includes hepatoprotective experiments, toxicity experiments and 
statistical analysis methods. 
 
2.2.2.1. Antihepatotoxic activity: 
Hepatoprotective activity was carried out by studying the effect of the two 
doses (200-400 mg/Kg) of aqueous and methanolic extracts of Dobera glabra 
leaves and Capparis decidua stem against CCl4 – induced hepatotoxicity in 
rats. The hepatoprotective activity of the tested plants was compared with the 
known hepatoprotective natural product, silymarin (from silybum marianum). 
2.2.2.1.1. Experimental procedure: 
The rats were weighed after the adaptation period and marked with serial 
numbers and divided randomly into 5 groups, 5 rats each, and then the doses 
were calculated according to individual body weights.  
 
2.2.2.1.1.1. Blood samples: 
Blood was obtained by puncturing retroorbital plexus (Poole, 1989), under 
anesthesia using Halothane and heparinized capillary tubes. Blood drops were 
collected, gently, serum was separated by centrifugation (2500 rpm for 15 
min), and EDTA was used as an anticoagulant for haematological parameters. 
Samples were collected before and after dosing with the tested plants extracts 
at day 0, 5 and at day 10.  
 
2.2.2.1.1.2. Assessment of liver function: 
Blood sample were collected into dry clean bottles and allowed to clot 
for 30 min at room temperature. Serum separated by centrifugation at 
2500 rpm for 15 min and stored at -20c° until analyzed. 
Biochemical parameters, i.e. alanine amino transeferase (ALT), aspartate 
amino transferase (AST), alkaline phosphatase (ALP), total bilirubin (TBIL) 
were analyzed according to the reported methods. 
 
2.2.2.1.1.2.1. Total Bilirubin:     
Total Bilirubin in serum is determined using the method of Jendrassik and 
Grof, (1938). 
Principle: 
Bilirubin in the presence of a sluphanlic acid diazonium salt from a red 
coloured azo compound in alkaline solution. Bilrubin is coupled with 
diazotized sulfanilic acid in the presence of caffeine to give an azo dye. 
The optical density was measured by spectrophotometer at wave length 546 
nm. 
Calculation: 
Total Bilirubin is calculated as follow: 
Absorbance tube Total × 17.5 = Total Bilirubin (mg/dl). 
 
2.2.2.1.1.2.2. Alkaline phosphatese: 
It is an optimized method according to recommendation of Chemie (1972). 
Principle: 
In Alkaline medium serum alkaline phosophates splits p- 
nitrophenylphosphate, in the presence of Mg+2 ions, into p-nitrophenyl and 
phosphate. At the PH of reaction, p-nitrophenyl was coloured yellow, the 
optical density measured in a spectrophotometer at wavelength    405nm. 
Reaction: 
P-nitrophenylphosphate + H2o   ALP    phosphate + p-nitrophenol 
Calculation: 
ALP is calculated as follows: 
U/1 = 2760 × A 405nm/min  
(A = the mean of sample absorbance reading) 
 
2.2.2.1.1.2.3. Alanine amino transeferase (ALT): 
It is an enzymatic method, which measure gultamic pyruive transamine in 
surem according to Reitman and Frankel (1957), and Schmidt and Schmidt, 
(1963). 
 
Principle: 
Alanine amino transfers is measured by monitoring the concentration of 
pyruive hydrazone formed with 2-4 dinitrophenylhydrazine . 
 
Reaction: 
α - oxoglutarate + L-alanine     ALT       L-glutrate + pyruivate    
 
The absorbance of samples was read against the reagent blank after 5min at 
wavelength 546 nm in spectrophotometer.  
 
2.2.2.1.1.2.4. Aspartate  amino transferase (AST): 
It is an enzymatic method that measure gultamic oxaloacetic transaminase in 
serum according to Reitman and Frankel (1957), and Schmidt and Schmidt, 
(1963). 
 
Principle: 
Aspartate amino transferase is measured by monitoring the concentration of 
oxaloacetate hydrozone formed with 2-4 dintrophenyl hydrazine. 
 
Reaction: 
α- oxoglutarate +L-aspartate    AST   L-glutarate + oxaloacetate    
  
The absorbance of samples was read against the reagent blank after 5min at 
wavelength 546 nm in spectrophotometer and cuvette of 1cm light path. 
 
2.2.2.1.1.3. Haematological studies: 
Haemoglobin concentration (Hb), packed cell volume (PCV), red blood cells 
count (RBC), mean corpuscular volume (MCV), and mean corpuscular 
hemoglobin concentration (MCHC), were measured. 
Blood samples were collected into dry clean bottles; the anticoagulant was 
ethylene diamine tetra acetic acid (EDTA). 
 
2.2.2.1.1.3.1. Packed cell volume (PCV): 
Packed cell volume was measured by place blood samples into a capillary 
haematocrit tube which sealed at one end with a special calay (cristaseal).The 
capillary tubes were centrifuged  in a microhaematocrit centrifuge  for 5 
minutes and the pcv value was  measured  from the scale on microhaematcnit 
reader (Schalm, 1965). 
 
2.2.2.1.1.3.2. Red blood cell count (RBCs): 
Total erthrocytes were counted by using Neubauer haemocytometer and 
Hayem's solution. (Kelly, 1984). 
Calculation: 
200 × 50 × R cells = 10.000 × R µl. 
 
2.2.2.1.1.3.3. Haemoglobin concentration (Hb): 
The concentration of Hb was measured by the cyanmethaemoglobin method 
(Kelly, 1984). 
The procedure consists of adding 20 µl of blood to 5 ml of a modified 
Drabkin's solution. After 10 min the solution of cyanmethaemoglobin is 
compared against a standard in either spectrophotometer (wavelength 540 nm).  
  
2.2.2.1.1.3.4. Mean corpuscular volume (MCV): 
The mean volume of the red corpuscle was calculated when the erythrocyte 
count and the volume of packed red cells are known (Maxweil and Wintrobe, 
1967). 
Calculation: 
 
            MCV =    Vol. packed red cells /ml per 1000 ml   (fl) 
                             Red cells count, millions per cmm 
2.2.2.1.1.3.5. Mean corpuscular haemoglobin concentration (MCHC): 
MCHC was calculated when the Hb concentration and the volume of packed 
red cells are known (Maxweil and Wintrobe, 1967). 
Calculation: 
 
                MCHC =      Haemoglobin /gm per 100 ml x100    (gm/dl) 
                                     Vol. packed red cells, ml per 100 ml 
 
2.2.2.1.1.4. Clinical signs:  
Clinical signs and mortality were recorded in all groups all over the period of 
the experiments. 
 
2.2.2.1.1.5. Histopathological study: 
At the end of the treatment, the animals were sacrificed by decapitation, and a 
post-mortem examination was performed. 
Small pieces of livers were collected in 10% neutral buffered formal saline for 
histopathological study. Section 5 – 6 µ were cut and stained by routine 
haematoxyline and eosine and observed under a photomicroscope.  
 
2.2.2.1.2. Experiments: 
Four experiments with rats were performed during the course of the study as 
the following: 
 
2.2.2.1.2.1. Hepatoprotective activity of Dobera glabra leaves water extract 
against CCl4 – induced liver damage in rats.  
25 adult male Wister albino rats, (95-117 gm) were used; the animals were 
grouped randomly into 5 groups of 5 rats each. 
Group A:    serving as control received only the vehicle liquid paraffin 
0.2 mg/Kg /day 1/p for 10 days. 
        Group B: serving as intoxicated control by given CCl4 – induced 
hepatotoxicity 0.2 mg/Kg /day 1/p in liquid paraffin (1:9) for 10 days. 
Group C:    serving as hepatoprotective drug control, rats were given 
CCl4 0.2 mg/Kg /day 1/p in liquid paraffin (1:9) for 10 days, and at the same 
time received orally silymarin suspended in 5% acacia mucilage at dose 100 
mg/Kg/day. 
           Group D: Rats were given CCl4 0.2 mg/Kg /day 1/p in liquid paraffin 
(1:9) for 10 days and simultaneous oral administration of the aqueous extract of 
Dobera glabra leaves at dose 200 mg /Kg. 
Group E: Rats were administered CCl4 0.2 mg/Kg /day 1/p in liquid 
paraffin (1:9) and simultaneous oral administration of the aqueous extract of 
Dobera glabra leaves at dose 400 mg/Kg. 
 2.2.2.1.2.2. Hepatoprotective activity of Dobera glabra leaves methanolic 
extract against CCl4 – induced liver damage in rats.  
25 adult male Wister albino rats, (70-135 gm) were used; the animals were 
grouped randomly into 5 groups of 5 rats each. 
Group A:    serving as control received only the vehicle liquid paraffin 
0.2 mg/Kg /day 1/p for 10 days. 
         Group B: serving as intoxicated control by given CCl4 – induced 
hepatotoxicity 0.2 mg/Kg /day 1/p in liquid paraffin (1:9) for 10 days. 
Group C:    serving as hepatoprotective drug control, rats were given 
CCl4 0.2 mg/Kg /day 1/p in liquid paraffin (1:9) for 10 days, and at the same 
time received orally silymarin suspended in 5% acacia mucilage at dose 100 
mg/Kg/day. 
           Group D: Rats were given CCl4 0.2 mg/Kg /day 1/p in liquid paraffin 
(1:9) for 10 days and simultaneous oral administration of the methanolic 
extract of Dobera glabra leaves at dose 200 mg /Kg. 
Group E: Rats were administered CCl4 0.2 mg/Kg /day 1/p in liquid 
paraffin (1:9) and simultaneous oral administration of the methanolic extract of 
Dobera glabra leaves at dose 400 mg/Kg. 
 
2.2.2.1.2.3. Hepatoprotective activity of Capparis decidua stems water 
extract against CCl4 – induced liver damage in rats.  
25 adult male Wister albino rats, (76-115 gm) were used; the animals were 
grouped randomly into 5 groups of 5 rats each. 
Group A:    serving as control received only the vehicle liquid paraffin 
0.2 mg/Kg /day 1/p for 10 days. 
         Group B: serving as intoxicated control by given CCl4 – induced 
hepatotoxicity 0.2 mg/Kg /day 1/p in liquid paraffin (1:9) for 10 days. 
Group C:    serving as hepatoprotective drug control, rats were given 
CCl4 0.2 mg/Kg /day 1/p in liquid paraffin (1:9) for 10 days, and at the same 
time received orally silymarin suspended in 5% acacia mucilage at dose 100 
mg/Kg/day. 
           Group D: Rats were given CCl4 0.2 mg/Kg /day 1/p in liquid paraffin 
(1:9) for 10 days and simultaneous oral administration of the aqueous extract of 
Capparis decidua stems at dose 200 mg /Kg. 
Group E: Rats were administered CCl4 0.2 mg/Kg /day 1/p in liquid 
paraffin (1:9) and simultaneous oral administration of the aqueous extract of 
Capparis decidua stems at dose 400 mg/Kg. 
 
 
2.2.2.1.2.4. Hepatoprotective activity of Capparis decidua stems methanolic 
extract against CCl4 – induced liver damage in rats.  
25 adult male Wister albino rats, (80-110 gm) were used; the animals were 
grouped randomly into 5 groups of 5 rats each. 
Group A:    serving as control received only the vehicle liquid paraffin 
0.2 mg/Kg /day 1/p for 10 days. 
         Group B: serving as intoxicated control by given CCl4 – induced 
hepatotoxicity 0.2 mg/Kg /day 1/p in liquid paraffin (1:9) for 10 days. 
Group C:    serving as hepatoprotective drug control, rats were given 
CCl4 0.2 mg/Kg /day 1/p in liquid paraffin (1:9) for 10 days, and at the same 
time received orally silymarin suspended in 5% acacia mucilage at dose 100 
mg/Kg/day. 
           Group D: Rats were given CCl4 0.2 mg/Kg /day 1/p in liquid paraffin 
(1:9) for 10 days and simultaneous oral administration of the methanolic 
extract of Capparis decidua stems at dose 200 mg /Kg. 
Group E: Rats were administered CCl4 0.2 mg/Kg /day 1/p in liquid 
paraffin (1:9) and simultaneous oral administration of the methanolic extract of 
Capparis decidua stems at dose 400 mg/Kg. 
 
2.2.2.1.3. Treatments: 
• CCl4 – induced hepatotoxicity was suspended in liquid paraffin (1:9) and 
administrated 1/p (ELHaj, 2001). 
• Liquid paraffin used as a vehicle and give to the control animal and 
injected 1/p. 
• Silymarin (hepatoprotector drug) was suspended in 5% w/v acacia 
mucilage and administered orally by nasogastric tube (Rao and Mishra, 
1998). 
• Aqueous and methanolic extracts of the tested part of plants (Dobera 
glabra leaves and Capparis deciduas stems), were dissolved in sterile 
distilled water and given orally by nasogastric tube (feeding tube). 
 
 
2.2.2.2. Toxicity: 
A toxicological study was conducted by studying the effect of two doses (200-
400 mg/ Kg) of aqueous and methanolic extract of the plant which possess 
hepatoprotective activity. 
 
2.2.2.2.1. Experimental procedure:  
Rats were weighted and randomized into 3 groups of 5 rats each, the control 
group was given only distilled water while the tested groups were received 
doses 200 mg/Kg and 400 mg/Kg b.w of the aqueous or methanolic extract of 
the active plant. 
Blood samples were collected before treatment at day "0", and after slaughter 
after 3 weeks, and analyzed for various biochemical and haematological 
parameters. 
Rats were observed for signs of toxicity and mortality. The specimens of liver, 
lung, heart, kidney, intestine, stomach and spleen were collected immediately 
after slaughtering and were fixed in 10% neutral buffer formal saline for 
histopathology. 
 
2.2.2.2.2. Experiments: 
Two experiments with rats were performed during the course of the study as 
the following: 
 
2.2.2.2.2.1. Toxicity of water extract of Capparis decidua stems in rats. 
15 adult Wister albino rats of either sex, (75- 90 gm) were used; the animals 
were randomized into 3 groups of 5 rats each. 
Group A: control animals receiving distilled water and allowed for 21                    
days. 
Group B: Rats were given 200 mg/Kg /day, of the aqueous extract of 
Capparis decidua stems orally, for 21 days.   
Group C: Rats were given 400 mg/Kg /day, of aqueous extract of 
Capparis decidua stems orally, for 21 days.  
 
2.2.2.2.2.2. Toxicity of methanolic extract of Capparis decidua stems in 
rats. 
15 adult Wister albino rats of either sex, (85-110 gm) were used; the animals 
were randomized into 3 groups of 5 rats each. 
Group 1: control animals receiving distilled water and allowed for 21                    
days. 
Group 2: Rats were given 200 mg/Kg /day, of the methanolic extract of 
Capparis decidua stems orally, for 21 days.   
Group 3: Rats were given 400 mg/Kg /day, of the methanolic extract of 
Capparis decidua stems orally, for 21 days.  
 
2.2.2.2.3. Treatments: 
• Aqueous and methanolic extracts of the tested part of plant 
(Capparis deciduas stems), were dissolved in sterile distilled 
water and given orally by nasogastric tube (feeding tube). 
  
 
 
2.2.2.3. Statistical analysis: 
Statistical analysis of data was performed using software Statistical Package 
for Social Sciences (SPSS). Mean values in serum parameters were compares 
using the student's t-test. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
3.1. Phytochemical parts  
 
3.1.1. The yield of extracts:  
Dobera glabra leaves and Capparis decidua stems were extracted with 
different solvents (chloroform, methanol, water) and the yield percentages are 
shown in Table (1).    
                                                                                
3.1.2. Phytochemical screening: 
The preliminary phytochemical analysis of the powdered material of plants 
revealed the presence of alkaloids, saponins, flavonoids, tannins, sterols, 
cyanogenic glucosides and cumarins in all tested plants. All these parts of 
plants were devoid of anthraquinone compound. 
The results are summarized in Table (2). 
 
3.1.3. Thin layer chromatography:  
The methanolic extract of Dobera glabra leaves and Capparis decidua stems 
were chromatographed on silica gel thin layer chromatography using Butanol 
Water Acetic Acid (40 – 50 – 10) as solvent system.  
The results are presented in Figure (4) and (5). 
 
  
 
 
 
 
 
  
Table (1) 
The yield of different extracts of Dobera glabra leaves and Capparis 
decidua stems. 
 
Yield  % 
 
Extract 
   
 
Quantity    
(g) 
 
Tested     
material 
 
Plant 
  
 
 
 
 
 
1.84 Chloroform 100 
10.14 Methanol 100 
9.95 Aqueous 100 
 
 
Leaves 
 
 
 
 
Dobera glabra 
1.45 Chloroform 60 
12.61 Methanol 60 
11.56 Aqueous 100 
 
 
Stems 
 
 
Capparis decidua 
           
         Table (2) 
                    Preliminary phytochemical screening of Dobera glabra leaves and Capparis decidua stems.  
 
 
 
 
 
 
 
 
 
 
 
              AL=alkaloids. FD=flavonoids. TN=tannins. SL=sterols. SN=saponins. CG=cyanogenic glucosides.                           
AN=anthraquinone glucosides. CU=cumarins. 
 
 
 
 
 
 
Phytoconstituents 
CU AN CG SN SL TN FD AL 
 
Tested plants 
 
+ 
 
– 
 
+ 
 
+ 
 
+ 
  
+ 
 
  
+ 
 
 
+ 
 
 
Dobera glabra  leaves 
 
+ 
 
– 
 
+ 
 
+ 
  
+ 
 
+ 
 
 
+ 
 
+ 
 
Capparis decidua stems 
 
 
 
 
 
 
 
 
 
Fig (4) Thin layer chromatography of Dobera glabra leaves methanolic extract. 
 
Key: 
              Adsorbant: silica gel DGF 254 
        Solvent system: BAW 
        Detection: sprayed with vanillin – sulphuric acid  
 
 
   
 
 
 
 
 
Fig (5) Thin layer chromatography of Capparis decidua stems methanolic extract. 
 
Key: 
              Adsorbant: silica gel DGF 254 
        Solvent system: BAW 
        Detection: sprayed with vanillin – sulphuric acid 
 
      3.2. Pharmacological parts 
 
3.2.1. Hepatoprotective Experiments: 
The aqueous and methanolic extracts of D. glabra leaves and C. decidua stems 
were tested for hepatoprotective activity in experimental laboratory animal 
(Wister albino rats) against CCl4 induced hepatotoxicity.  
 
3.2.1.1. Effect of Dobera glabra leaves water extract against CCl4 
- induced liver damage in rats:  
The experimental design, doses and times of slaughtering are presented in 
Table (3).  
 
3.2.1.1.1. Clinical finding:- 
After injection of CCl4 there were slight convulsion, depression and loss of 
appetite in all groups except group A (control group) and group C (standard 
drug group). 
 
3.2.1.1.2. Post-mortem changes:- 
In group B (CCl4-induced liver damage), fatty changes, piteacheal 
haemorrhage and adhesions in all lobes of the liver were observed. 
In group C (standard drug), there was slight fatty change in one lobe and 
piteacheal haemorrhage. 
In group D (200 mg/kg) and group E (400 mg/kg), the livers were fragile with 
generalized and severe fatty changes, increase in liver size and piteacheal 
haemorrhage. Also there were scattered spots of necrosis in the upper surface 
of the liver especially in group E. 
No significant changes were observed in group A (control group). 
  
Table (3)  
Experimental plan of rats given D. glabra leaves water extract 
simultaneously with CCl4.                                                                                    
 
Groups Animals 
No 
 Doses  
 
Time of 
slaughtering  
Group A 
(Control) 
 
 
 
5 rats 
 
 
 
0.2 ml/kg liquid 
paraffin               
I/P 
 
 
10 days  
 
 
Group B 
(CCl4 
control) 
 
 
 
5 rats 
 
 
 
0.2 ml/kg CCl4 
in liquid paraffin (1:9)  
I/P 
 
 
10 days  
 
 
Group C 
Standard drug 
 
 
 
5 rats 
 
 
0.2 ml/kg CCl4              
in liquid paraffin (1:9) 
I/P + 100 mg/kg of 
silymarin in 5% acacia 
mucilage orally 
 
 
10 days  
 
 
Group E 
200 mg/kg     D. 
glabra leaves 
 
 
 
5 rats 
  
  
0.2 ml/kg CCl4              
in  liquid paraffin (1:9) 
I/P + 200 mg/kg of     
D. glabra leaves water 
extract orally 
 
 
10 days  
 
 
Group D 
400 mg/kg     D. 
glabra leaves 
 
 
 
5 rats 
0.2 ml/kg CCl4              
in liquid paraffin (1:9) 
I/P + 400 mg/kg of     
D. glabra leaves water 
extract orally 
 
 
10 days  
 
 
 
 
3.2.1.1.3. Change in serum constituents:- 
These parameters are given in Table (4), Figures (6), (7), (8) and (9).  
In CCl4 group (B), the concentration of bilirubin and the activities of AST, 
ALT and ALP were significantly (P < 0.01 – 0.001) increased when compared 
with the untreated group (A) and the standard drug group (C), throughout the 
period of experiment. 
simultaneous treatment with water extract of Dobera glabra leaves to rats in 
group D (200 mg/kg) and group E (400 mg/kg) increased the activities of 
serum AST, ALT and ALP and concentration of bilirubin (P < 0.05 – 0.01- 
0.001) when they compared with group C. 
 
3.2.1.1.4 Haematological changes:-   
The mean values of Hb, PCV, RBCs, and MCV and MCHC are presented in 
Table (5). 
In group B there were significant decreases in the values of Hb, PCV, RBCs 
and MCHC (P < 0.05 - 0.01 - 0.001), and significant increase in MCV values 
(P < 0.05 – 0.01 - 0.001). 
In group D there was a significant decrease in the values of RBCs (P < 0.01), 
and significant increase in MCV values (P < 0.05 – 0.01). In group E there 
were significant decreases in the values of PCV, Hb, RBCs (P < 0.05 - 0.001) 
and significant increase of MCV values (P < 0.05 – 0.01). 
 
3.2.1.1.5 Histopathological changes: 
Histopathological sections of the experiment are presented in Figure 10 (a - e). 
In CCl4 group significant changes were observed in the liver which induced 
diffuse areas of vacuolar degeneration, mainly centrilobular. Swelling of cells 
and congestion of hepatic veins and sinusoids. 
Table (4) Effect of D. glabra leaves water extract administered simultaneously with CCl4 on serum   
constituents levels on rats:  
Bilirubin mg/dl (Mean ± S.E.) ALP U/I (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 0.15 ± 0.02         0.18 ± 0.03 °° 
                           **  
      0.17 ± 0.04  °°° 
                          ** 
372.8 ± 44.68        452.2 ± 78.98°°   364.6 ± 25.07  °°° 
B 0.23 ± 0.03     0.51 ± 0.09       0.95 ± 0.07    
*** 
266.9 ± 30.30   895.0 ± 45.67    
   *** 
  1007.8 ± 70.76   
                          *** 
C 0.22 ± 0.02     0.41 ± 0.04             0.35 ± 0.03  °°°   
 
376.4 ± 27.07       473.2 ± 37.82°°°   481.5 ± 46.73 °°° 
D 0.21 ± 0.05     0.53 ± 0.06       0.89 ± 0.13      
** 
320.7 ± 15.81 778.7 ± 60.00  
     ** 
    924.9 ± 66.10  
   ** 
E 0.18 ± 0.03     0.53 ± 0.06       0.95 ± 0.10     
*** 
313.7 ± 32.92 851.8 ± 33.10  
  *** 
1114.5 ± 111.72   
** 
 
AST U/I (Mean ± S.E.) ALT U/I (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A  28.8 ± 3.29 
 
      31.6 ± 4.87  °°° 
                          *    
      39.2 ± 4.90     °° 30.2 ± 4.68       21.4 ± 4.68  °°°       27.2 ± 6.85    °° 
B 40.8 ± 6.93 215.6 ± 13.08 
                           *** 
286.4 ± 45.30  
      ** 
29.0 ± 2.77 74.0 ± 5.44   
                            * 
   115.6 ± 16.29   
                            ** 
C 37.2 ± 1.36 
 
       62.0 ± 11.48 °°°      62.8 ± 14.84   °° 32.4 ± 4.53      46.0 ± 7.40 °        50.8 ± 8.14   °° 
D 37.6 ± 2.79 
 
159.0 ± 21.45 
                          ** 
287.6 ± 18.72  
      *** 
 30.6 ± 5.41   70.8 ± 6.44  
                             * 
101.6 ± 6.76  
       ** 
E 37.6 ± 3.74 
 
211.8 ± 10.1 
                         *** 
     331.6 ± 14.60 
                           *** 
31.4 ± 3.20   85.8 ± 9.28  
                             * 
127.6 ± 17.22  
                            ** 
A (control group), B (CCl4 group), C (standard drug group), D (200mg/kg plant) and E (400mg/kg plant). 
The difference was found to be significant (º P < 0.05   ºº P < 0.01  ººº P< 0.001) when compared with group B (CCl4 group), and significant (* P < 0.05  ** P < 
0.01 *** P < 0.001) when compared with group C (standard drug group).    
  
Fig. (6) Effect of D. glabra leaves water extract administered 
simultaneously with CCl4 on serum bilirubin concentration on rats. 
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Fig. (7) Effect of D. glabra leaves water extract administered 
simultaneously with CCl4 on serum alkaline phosphatase levels on rats.  
             
 
 
 
 
 
 (a)  
 
  
      
 
 
 
 
 (b)  
 
 
 
     
 
 
0
200
400
600
800
1000
1200
day 0 day 5 day 10
Days
A
LP
 U
/I
Control
CCl4
Standard drug
200 mg/kg
400 mg/kg
0
200
400
600
800
1000
1200
day 0 day 5 day 10
Days
AL
P 
U/
I
Control
CCl4
Standard drug
200 mg/kg
400 mg/kg
  
Fig. (8) Effect of D. glabra leaves water extract administered 
simultaneously with CCl4 on AST levels on rats. 
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Fig. (9) Effect of D. glabra leaves water extract administered 
simultaneously with CCl4 on ALT levels on rats. 
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Table (5). Effect of D. glabra leaves water extract administered simultaneously with CCl4 on haematological 
values on rats.  
Hb (g/dl) (Mean ± S.E.) PCV (%) (Mean ± S.E.) MCV (fl) (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 11.2 ± 0.38   10.8 ± 0.31 10.8 ± 0.29°° 
 
33.4 ± 1.21  32.2 ± 0.86°  32.0 ± 0.71  66.0 ± 3.17 72.2 ± 2.62 70.3 ± 3.27  
B 12.3 ± 0.44 10.1 ± 0.39 7.5 ± 0.83 
                  **   
34.2 ± 1.02 29.2 ± 0.86  30.6 ± 2.06 74.0 ±1.66 94.7 ± 7.22 º 117.4±6.70  
                 ** 
C 10.9 ± 0.28 10.7 ± 0.47 11.3 ± 0.35°° 
 
32.0 ± 0.89 30.6 ± 0.51 34.0 ± 0.71  67.5 ± 4.44 77.8 ± 3.16 78.9 ± 3.10°° 
D 12.3 ± 0.60 12.2 ± 0.57 ° 11.5 ± 1.07° 34.8 ± 0.49 32.4 ± 1.12   36.2 ± 2.17  73.5 ± 4.40 96.6 ± 6.51 
                    *   
127.9±9.80   
                  **
E 12.0 ± 0.37 10.9 ± 0.26 8.4 ± 0.89  
 *   
33.8 ± 0.58 32.8 ± 0.37°° 
**   
26.2 ± 2.08 
                **   
74.5 ± 3.31 89.9±2.47 
  *   
105.1±5.91      
                  **   
 
 
RBC (x 106) (Mean ± S.E.) MCHC (%) (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 5.13 ± 0.38     4.48 ± 0.19  °° 
 
      4.61 ± 0.33°° 33.5 ± 0.09 33.4 ± 0.12      33.7 ± 0.39 ° 
B 4.62 ± 0.15 3.16 ± 0.27  
                        * 
2.61 ± 0.15  
                          *** 
36.0 ± 1.37 34.4 ± 0.79          24.3 ± 1.63  
                           ** 
C 4.82 ± 0.35     3.96 ± 0.17  ° 
 
     4.35 ± 0.26 °°° 34.0 ± 0.86 34.8 ± 1.24      33.3 ± 0.56 °° 
D 4.83 ± 0.38  3.41 ± 0.22  
 
 2.86 ± 0.15   
                             **
35.5 ± 2.21 37.7 ± 2.22     32.2 ± 0.68 °° 
E 4.58 ± 0.23 3.66 ± 0.11   
 
2.51 ± 0.18   
                           ***
35.5 ± 0.87 33.3 ± 0.57    31.9 ± 1.16 °° 
A (control group), B (CCl4 group), C (standard drug group), D (200 mg/kg plant) and E (400 mg/kg plant). 
The difference was found to be significant (º P < 0.05   ºº P < 0.01 ººº P< 0.001) when compared with group B (CCl4 group), and significant (* P < 0.05 ** P < 
0.01 *** P < 0.001) when compared with group C (standard drug group).   
In some areas hepatic cords were disturbed and hepatocyte degeneration was 
evident .Affected cells showed pyknotic nuclei.  Mononuclear cell infiltration 
in parenchyma and around the portal area and dilation of sinusoids were also 
seen. 
The interlobular bounders appear to be distinct with slight proliferation of 
fibrous tissues and the lobular structure was not regular, there was bile duct 
proliferation in the portal areas. 
Most these degenerative changes appeared to be more pronounced around the 
central veins saving the peripheral areas.   
In group D (200 mg/kg) sections showed hepatocytes degeneration in the form 
of small vacuoles or large cytoplasmic vacuoles or fragmented cytoplasm and 
necrosis with loss of cell bounders, associated sometimes with kupffer cells 
proliferation. 
Nuclei of affected cells showed pyknosis and karyolysis and in some cells 
showed mitotic activity. 
Congestion and dilation of portal vessels with bile ductule hyperplasia were 
observed .The bile duct epithelium appear to be swollen and irregularity 
arranged. These changes appear to be centrilobular.  
In group E (400 mg/kg) sections showed more diffuse vacuolar degeneration 
and areas of necrosis characterized by disintegration and disappearance of cells 
in many areas. Congestion of blood vessels was a distinct feature. In some 
areas there was also mononuclear cell infiltration around the portal veins.   
Moreover, bile duct hyperplasia and swelling of duct epithelium were evident. 
All these changes appeared to start centrilobularly spreading to involve most of 
hepatic lobules saving the peripheral areas. 
In group C mild to moderate changes were noticed, vacuolar degeneration 
which appear to be peripherally in the lobules. Some hepatocytes contained 
small single 
or multiple cytoplasmic vacuoles.  Hepatocyte swelling and congestion were 
also observed.   
Control group showed no significant change in liver sections.  
Some foci of mononuclear cell infiltration were seen in the liver parenchyma 
(these are often seen in normal liver tissue of rats). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (10) Histopathological changes in the livers of rats given water extract 
of Dobera glabra leaves simultaneously with CCl4. 
 
 
(a)               
 
 
 
 
 
 
 
 
 
 
 
              
(b)                                                                                 (c)   
                   (e) (d) 
 
a) Liver section (control group), showing normal histological appearance. H&E × 40.  
b) Liver section, standard drug group, showing mild hepatocyte vacuolation. H&E × 40. 
c) Liver section, CCl4 group, showing diffuse areas of vacuolar degeneration and 
centrilobular necrosis with mononuclear cell infiltration. H&E × 40. 
d) Liver section, rats treated with 200 mg/kg D. glabra: showing diffuse areas of 
vacuolar degeneration and centrilobular necrosis. H&E × 40. 
e) Liver section, group received 400 mg/kg D. glabra: showing massive vacuolar 
degeneration and necrosis involving most of the lobules. H&E × 40.   
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.1.2. Effect of Dobera glabra leaves methanolic extract against 
CCl4 – induced liver damage in rats:- 
The experimental plan of the experiment is presented in Table (6). 
 
3.2.1.2.1. Clinical finding: 
Depression, slight convulsion and loss of appetite were observed during the 
experiment after injection of CCl4 in all groups with the exception of group A 
and C. 
 
3.2.1.2.2. Post-mortem finding: 
Mark congestion, severe fatty changes, piteacheal haemorrhage and adhesions 
in all lobes of the liver were observed in CCl4 group B and group D and E. 
There were some spots of necrosis in the surface of the liver and the tissue 
showed very fragile and large in size especially in group E. 
 
3.2.1.2.3. Changes in serum constituent:  
These parameters are given in Table (7), and Figures (11), (12), (13) and (14).   
Administration of CCl4 caused significant increase in serum AST, ALT, ALP 
levels and bilirubin concentrations in rats when compared to control and 
standard drug group (P < 0.05 - 0.01 - 0.001).   
Simultaneously treatment with methanolic extract of Dobera glabra leaves 
significantly (P < 0.05 – 0.01 - 0.001) increase these levels when compared 
with group A and C. 
 
3.2.1.2.4. Haematological finding: 
The mean value of Hb, PCV, MCV, RBCs and MCHC are given in table (8). 
In CCl4 group there were significant decrease in the values of HB, RBC and 
MCHC (P < 0.05 – 0.01 - 0.001) and significant increase in MCV values (P < 
0.05 – 0.01 - 0.001). 
In group D there were significant decreases in the values of RBCs and MCHC 
(P < 0.05 – 0.01) and significant increase in MCV values (P < 0.05). In group 
E there was significant decrease HB, RBC and MCHC (P < 0.05 – 0.01 – 
0.001) and significant increase in PCV and MCV values (P < 0.05), when 
compared with group A and C. 
No significant change in the control and standard drug groups. 
 
3.2.1.2.5. Histopathological finding: 
The results of histopathological changes of the experiment are presented in 
figure 15 (a - e). 
In group D (200 mg/kg), hepatocytes contained multiple small vacuolation at 
many places. Hepatocytes appeared swollen with fragmented or granular 
cytoplasm.   
In group E (400mg/kg), showed diffuse vacuolar degeneration with swollen 
hepatocytes. Fragmentation of cytoplasm, cytoplasmolysis and total 
disappearance of cells were observed. 
Nuclei were displaced and can be seen any where in the cytoplasm of affected 
cells. Apparently normal cells contain small vacuolation.  
  
 
 
 
 
 
 
 
 
Table (6)  
Experimental plan of rats given D. glabra leaves methanolic extract 
simultaneously with CCl4.                                                                                    
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Groups 
 
Animals 
No 
Doses Time of 
slaughtering 
Group A 
(Control) 
 
  
  
5 rats    
 
0.2 ml/kg liquid 
paraffin I/P 
 
 
10 days  
 
 
Group B 
(CCl4 
control) 
 
  
  
 5 rats 
 
0.2 ml/kg CCl4 
in liquid paraffin (1:9)  
I/P 
 
 
10 days  
 
 
Group C 
Standard 
drug 
 
  
 
5 rats  
 
 
0.2 ml/kg CCl4 
in liquid paraffin (1:9) 
I/P + 100 mg/kg of 
silymarin in 5% acacia 
mucilage orally 
 
 
10 days  
 
 
Group D 
200 mg/kg    
D. glabra 
leaves 
 
  
  
 5 rats 
0.2 ml/kg CCl4 
in  liquid paraffin (1:9) 
I/P + 200 mg/kg of     
D. glabra leaves 
methanolic extract 
orally 
 
 
10 days  
 
 
Group E 
400 mg/kg    
D. glabra 
leaves 
 
  
 
 5 rats 
  
  
0.2 ml/kg CCl4 
in liquid paraffin (1:9) 
I/P + 400 mg/kg of     
D. glabra leaves 
methanolic extract 
orally 
 
 
10 days  
 
 
 Table (7) Effect of D. glabra leaves methanolic extract administered simultaneously with CCl4 on serum   
constituents levels on rats:  
Bilirubin mg/dl (Mean ± S.E.) ALP U/I (Mean ± S.E.) Groups 
Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 0.15 ± 0.02  0.18 ± 0.03   °° 
                      ** 
   0.17 ± 0.04   °°° 
                        ** 
372.8 ± 44.68      452.2 ± 78.98 °°     364.6 ± 25.07°°° 
B 0.23 ± 0.03      0.51 ± 0.09          0.95 ± 0.07    
*** 
266.9 ± 30.30 895.0 ± 45.67  
     *** 
   1007.8 ± 70.76  
  *** 
C 0.22 ± 0.02      0.41 ± 0.04         0.35 ± 0.03    °ºº 
 
376.4 ± 27.07     473.2 ± 37.82°°°     481.5 ± 46.73°°° 
D 0.16 ± 0.02      0.42 ± 0.07           0.71 ± 0.07    º 
                        ** 
375.0 ± 58.54 940.0 ± 44.32   
                         *** 
1179.4 ± 80.05  
                        *** 
E 0.15 ± 0.02      0.62 ± 0.06   
                           * 
    1.06 ± 0.18     
*** 
347.0 ± 53.04 984.2 ± 65.16 
*** 
1142.0 ± 60.32  
                       *** 
 
 
AST U/I (Mean ± S.E.) ALT U/I (Mean ± S.E.) Groups 
Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A  28.8 ± 3.29 
 
    31.6 ± 4.87   °°° 
                          * 
     39.2 ± 4.90    °° 30.2 ± 4.68     21.4 ± 4.68 °°° 
                        * 
    27.2 ± 6.85  °° 
B 40.8 ± 6.93 215.6 ± 13.08    
                         ***  
286.4 ± 45.30  
      ** 
29.0 ± 2.77        74.0 ± 5.44    
                        * 
115.6 ± 16.29  
                           ** 
C 37.2 ± 1.36 
 
     62.0 ± 11.48 °°°      62.8 ± 14.84   °° 32.4 ± 4.53   46.0 ± 7.40   º     50.8 ± 8.14    °° 
D 46.4 ± 9.01 
 
220.0 ± 31.81  
** 
315.4 ± 53.09  
** 
 32.2 ± 3.29    89.8 ± 10.77  
                            * 
      99.0 ± 5.77   
                          ** 
E 51.2 ± 10.54 
 
259.4 ± 26.66 
*** 
450.4 ± 78.12 
** 
29.6 ± 3.23 87.6 ± 7.87  
** 
111.0 ± 6.78 
*** 
A (control group), B (CCl4 group), C (standard drug group), D (200mg/kg plant) and E (400mg/kg plant). 
The difference was found to be significant (º P < 0.05   ºº P < 0.01  ººº P< 0.001) when compared with group B (CCl4 group), and significant (* P < 0.05  ** P < 
0.01 *** P < 0.001) when compared with group C (standard drug group).    
  
Fig. (11) Effect of D. glabra leaves methanolic extract administered 
simultaneously with CCl4 on serum bilirubin concentration on rats. 
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Fig. (12) Effect of D. glabra leaves methanolic extract administered 
simultaneously with CCl4 on serum alkaline phosphatase levels on rats.  
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Fig. (13) Effect of D. glabra leaves methanolic extract administered 
simultaneously with CCl4 on AST levels on rats. 
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Fig. (14) Effect of D. glabra leaves methanolic extract administered 
simultaneously with CCl4 on ALT levels on rats. 
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Table (8) Effect of D. glabra leaves methanolic extract administered simultaneously with CCl4 on 
haematological values on rats.  
Hb (g/dl) (Mean ± S.E.) PCV (%) (Mean ± S.E.) MCV (fl) (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 11.2 ± 0.38   10.8 ± 0.31 10.8 ± 0.29°° 
 
33.4 ± 1.21  32.2 ± 0.86° 32.0 ± 0.71°  66.0 ± 3.17 72.2 ± 2.62° 70.3 ±3.27°°°   
B 12.3 ± 0.44 10.1 ± 0.39 
 
 7.5 ± 0.83 
                  **   
34.2 ± 1.02 29.2 ± 0.86   30.6 ± 2.06 74.0 ±1.66 94.7 ± 7.22  117.4±6.70 
                  ** 
C 10.9 ± 0.28 10.7 ± 0.47 11.3 ± 0.35°° 
 
32.0 ± 0.89 30.6 ± 0.51 34.0 ± 0.71  67.5 ± 4.44 77.8 ± 3.16 78.9 ± 3.10°° 
D 10.9 ± 0.56 11.9 ± 1.42 10.0 ± 0.78 33.6 ± 1.29 32.2 ± 1.02   33.0 ± 1.97  76.4 ± 3.31 82.7 ± 4.87  109.4±10.68 
*   
E 11.7 ± 0.28 12.3 ± 1.35 10.5 ± 0.56°   33.0 ± 0.77 34.0 ± 1.84°   43.0 ± 3.48 º  
*   
66.4 ± 4.59 88.0 ± 3.92    113.3±12.67 
*   
 
 
RBC (x 106) (Mean ± S.E.) MCHC (%) (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 5.13 ± 0.38     4.48 ± 0.19  °° 
 
      4.61 ± 0.33 33.5 ± 0.09 33.4 ± 0.12      33.7 ± 0.39   °° 
B 4.62 ± 0.15 3.16 ± 0.27   
                       * 
        2.61 ± 0.15 
                           ***
36.0 ± 1.37 34.4 ± 0.79        24.3 ± 1.63   
                           ** 
C 4.82 ± 0.35    3.96 ± 0.17  ° 
 
        4.35 ± 0.26°°° 34.0 ± 0.86 34.8 ± 1.24       33.3 ± 0.56  °° 
D 4.45 ± 0.34 3.95 ± 0.26   
 
         3.09 ± 0.26  
                         ** 
32.3 ± 1.02 36.6 ± 3.43       30.3 ± 1.09   º   
                            * 
E 5.03 ± 0.37 3.90 ± 0.31    
 
       3.84 ± 0.13°°°   35.6 ± 0.98 36.9± 1.64 24.7 ± 1.58  
       **
A (control group), B (CCl4 group), C (standard drug group), D (200 mg/kg plant) and E (400 mg/kg plant). 
The difference was found to be significant (º P < 0.05   ºº P < 0.01 ººº P< 0.001) when compared with group B (CCl4 group), and significant (* P < 0.05 ** P < 
0.01 *** P < 0.001) when compared with group C (standard drug group).    
 
Fig. (15) Histopathological changes in the livers of rats given methanolic 
extract of Dobera glabra leaves simultaneously with CCl4. 
 
(a) 
 
 
 
 
 
 
 
 
 
 
 
              
(b)                                                                                (c) 
(e)                                                    (d) 
 
 
a) Liver section (control group), showing normal histological appearance. H&E × 40.  
b) Liver section, standard drug group, showing mild hepatocyte vacuolation. H&E × 40. 
c) Liver section, CCl4 group, showing diffuse areas of vacuolar degeneration and 
centrilobular necrosis with mononuclear cell infiltration. H&E × 40. 
d) Liver section, rats treated with 200 mg/kg D. glabra: showing massive vacuolar 
degeneration and centrilobular necrosis. H&E × 40. 
e) Liver section, group received 400 mg/kg D. glabra: showing mark vacuolar 
degeneration and diffuse areas of necrosis involving most of the lobules.  H&E × 40.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.1.3. Effect of Capparis decidua stems water extract against 
CCl4 - induced liver damage in rats: 
The experimental plan and doses are given in Table (9). 
 
3.2.1.3.1. Clinical finding: 
There were no any obvious clinical signs in all groups, except in CCl4 group 
there were slight depression and loss of appetite. 
 
3.2.1.3.2. Post-mortem changes: 
In CCl4- group B, showed generalized fatty changes, piteacheal haemorrhage 
and adhesions in all lobes of the liver. 
In group C (standard drug), there were slight fatty change in one lobe and 
piteacheal haemorrhage. 
In group D (200 mg /kg) there weren’t any abnormalities seen except 
piteacheal haemorrhage and slight fatty changes in the livers. 
In group E (400 mg/kg) congestion and slight fatty changes in one lobe of the 
livers were seen. 
No significant changes were observed in group (A) control group except slight 
congestion. 
 
3.2.1.3.3. Changes in serum constituent: 
These parameters are presented in Table (10) Figure (16), (17), (18) and (19). 
There were no significant changes in the concentration of bilirubin and in AST, 
ALT and ALP levels in the control group A and standard drug group C. 
In CCl4 the concentration of bilirubin and the activities of AST, ALT and ALP 
were significantly (P< 0.001) increased when compared with the standard drug 
silymarin group C. 
Simultaneously treatment with water extract of Capparis decidua stems to rats 
in group D (200 mg/kg) and group E (400 mg/kg) significantly (P< 0.001) 
reduce the activities of serum AST, ALT and ALP and concentration of 
bilirubin especially in group D (200 mg/kg) comparable with group B (CCl4 
group) . There weren’t any significant changes in this values when compared 
with group C (standard drug group).  
 
3.2.1.3.4. Haematological changes:-   
The mean value of Hb, PCV, MCV, RBCs and MCHC are given in Table (11). 
In CCl4 group there were significant decrease in the values of HB, RBC and 
MCHC (P < 0.01 - 0.001) and increase in MCV values (P< 0.001) when 
compared with group C.  
In group D there were significant decrease in the values of Hb, RBC and 
MCHC (P< 0.001) and increase in PCV and MCV values. 
No significant change in the control and standard drug groups. 
 
3.2.1.3.5. Histopathological changes: 
Histopathological sections of the livers are presented in Fig. 20 (a - e). 
Group D (200 mg/kg) showed very little changes in hepatocytes, however 
some hepatocytes appeared swollen and there were fragmentation or 
dissolution of cytoplasm. Vacuolation have a patchy distribution but very mild. 
Group E (400 mg/kg) showed mild to moderate vacuolar changes with 
hepatocyte swelling and fragmentation or lysis of cytoplasm. These vacuolar 
changes appear more peripherally in the lobules. 
 
 
 
 
  
Table (9)                                                                                                                 
Experimental design of rats given C. decidua stems water extract 
simultaneously with CCl4.                                                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Groups 
 
Animals 
No 
Doses Time of 
slaughtering
Group A 
(Control) 
 
 
 
5 rats 
 
0.2 ml/kg liquid 
paraffin I/P 
 
 
10 days  
 
 
Group B 
(CCl4 
control) 
 
 
 
5 rats 
 
0.2 ml/kg CCl4 
in liquid paraffin (1:9)  
I/P 
 
 
10 days  
 
 
Group C 
Standard 
drug 
 
 
 
5 rats 
0.2 ml/kg CCl4 
in liquid paraffin (1:9) 
I/P + 100 mg/kg of 
silymarin in 5% acacia 
mucilage orally 
 
 
10 days  
 
 
Group D 
200 mg/kg    
C.decidua 
stems 
 
 
5 rats 
0.2 ml/kg CCl4 
in  liquid paraffin (1:9) 
I/P + 200 mg/kg of     
C. decidua stems water 
extract orally 
 
 
10 days  
 
 
Group E 
400 mg/kg    
C. decidua 
stems 
 
 
 
5 rats 
0.2 ml/kg CCl4 
in liquid paraffin (1:9) 
I/P + 400 mg/kg of     
C. decidua stems water 
extract orally 
 
 
10 days  
 
 
 Table (10) Effect of C. decidua stems water extract administered simultaneously with CCl4 on serum   
constituents levels on rats:  
Bilirubin mg/dl (Mean ± S.E.) ALP U/I (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 0.21 ± 0.04 0.17 ± 0.03 °°° 
                   ** 
0.17 ± 0.02 °°° 
                 
403.1 ± 24.85 396.0 ± 65.94 °°° 402.0 ± 60.25 °°° 
B 0.22 ± 0.03      0.81 ± 0.03 
                   *** 
     1.04 ± 0.06 
                   *** 
398.1 ± 27.72    906.1 ± 35.73 
                       *** 
 1158.1 ± 58.43 
                      *** 
C 0.20 ±0.03      0.36 ± 0.04 °°° 0.28 ± 0.06 °°° 
 
486.5 ± 7.63 516.7 ± 16.35 °°° 537.1 ± 22.37 °°° 
D 0.21 ± 0.04      0.32 ± 0.05 °°° 
                 
0.26 ± 0.02 °°° 
                 
417.0 ± 21.6 515.2 ± 25.05 °°° 520.4 ± 28.80 °°° 
E 0.17 ± 0.03 0.35 ± 3.56 °°° 0.26 ± 0.04 °°° 
 
409.6 ± 10.25 501.7 ± 27.23 °°° 551.8 ± 13.47 °°° 
  
 
AST U/I (Mean ± S.E.) ALT U/I (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 35.2 ± 4.93 33.8 ± 3.87 °°° 
                   * 
33.8 ± 4.02 °°° 23.2 ± 5.50 25.2 ± 4.78 °°° 22.6 ± 4.41 °°° 
B 27.4 ± 2.64    188.2 ± 16.42 
                   *** 
   198.2 ± 18.78 
                    *** 
21.2 ± 3.51      89.2 ± 4.76 
                   *** 
   102.2 ± 7.42 
                   *** 
C 30.4 ± 1.54  48.6 ± 3.59 °°° 
 
42.4 ± 7.29 °°° 24.2 ± 4.41 29.2 ± 2.03 °°° 36.4 ± 3.40 °°° 
D 31.0 ± 2.43 48.0 ± 8.79 °°° 
 
39.2 ± 2.65 °°° 
                 
29.4 ± 4.34   35.4 ± 10.37 °°° 
                 
34.6 ± 1.69 °°° 
                 
E 35.4 ± 3.56 45.2 ± 5.99 °°° 
 
50.8 ± 3.10 °°° 31.2 ± 1.83 38.6 ± 6.74 °°° 
                 
40.4 ± 2.93 °°° 
A (control group), B (CCl4 group), C (standard drug group), D (200 mg/kg plant) and E (400 mg/kg plant). 
The difference was found to be significant (º P < 0.05   ºº P < 0.01 ººº P< 0.001) when compared with group B (CCl4 group), and significant (* P < 0.05 **  
P < 0.01 *** P < 0.001) when compared with group C (standard drug group).  
 
 
  
Fig. (16) Effect of C. decidua stems water extract administered 
simultaneously with CCl4 on serum bilirubin concentration on rats. 
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Fig. (17) Effect of C. decidua stems water extract administered 
simultaneously with CCl4 on serum alkaline phosphatase levels on rats. 
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Fig. (18) Effect of C. decidua stems water extract administered 
simultaneously with CCl4 on AST levels on rats. 
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Fig. (19) Effect of C. decidua stems water extract administered 
simultaneously with CCl4 on ALT levels on rats. 
  
                
 
 
 
 
(a) 
 
 
                
 
 
 
 
 
(b) 
 
0
20
40
60
80
100
120
day 0 day 5 day 10
Days
A
LT
 U
/I
Control
CCl4
Standard drug
200 mg/kg
400 mg/kg
0
20
40
60
80
100
120
day 0 day 5 day 10
Days
A
LT
 U
/I
Control
CCl4
Standard drug
200 mg/kg
400 mg/kg
 Table (11) Effect of C. decidua stems water extract administered simultaneously with CCl4 on haematological 
values on rats.  
Hb (g/dl) (Mean ± S.E.) PCV (%) (Mean ± S.E.) MCV (fl) (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 12.1 ± 2.13 11.4 ± 0.67 11.6 ± 0.81°° 34.2 ± 2.13 33.4 ± 1.69 33.6 ± 2.16 70.0 ± 1.80 73.7 ± 1.72 
                  * 
73.1± 1.61°°° 
 
B 11.8 ± 0.58 10.3 ± 0.30 8.0 ± 0.48  
                  ** 
33.0 ± 1.48 31.4 ± 1.63 33.4 ± 1.50 78.4 ± 1.53 87.2 ± 9.58 117.0±4.75 
               *** 
C 10.2 ± 0.63 10.3 ± 0.42 11.0 ± 0.60°° 31.0 ± 1.58 30.8 ± 1.28 32.4 ± 1.33 71.1 ± 5.33 84.9 ± 3.90 71.3± 2.51°°° 
 
D 10.5 ± 0.24 10.6 ± 0.94 10.9 ± 0.44°° 30.6 ± 0.60 30.4 ± 2.11 32.2 ± 1.24 73.4 ± 3.32 81.3 ± 1.25 
             
77.5± 3.45°°° 
 
E 10.3 ± 0.20 11.3 ± 0.37 12.2± 0.37°°° 30.8 ± 0.58 33.8 ± 1.02 36.8 ± 1.16 
                  * 
74.7 ± 1.98 75.5 ± 2.02 
             
77.0± 1.09°°° 
             
 
 
RBC (x 106) (Mean ± S.E.) MCHC (%) (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 4.87 ± 0.23 4.53 ± 0.18 
                      * 
4.60 ± 0.31°° 35.4 ± 0.52 34.2 ± 0.68 34.6 ± 0.78 °°° 
B 4.23 ± 0.26 3.81 ± 0.48 
 
      2.88 ± 0.17 
                     *** 
35.7 ± 1.04 33.1 ± 1.31      24.1 ± 0.56 
                    *** 
C 4.39 ± 0.11 3.66 ± 0.25 
 
4.54 ± 0.09 °°° 32.7 ± 0.51 33.3 ± 0.04 33.7 ± 0.59 °°° 
D 4.23 ± 0.30 3.74 ± 0.25 
 
     4.22 ± 0.37 ° 33.6 ± 0.35 34.7 ± 1.30 33.8 ± 0.20 °°° 
E 4.14 ± 0.17   4.49 ± 0.18 ° 
                     * 
4.78 ± 0.20 °°° 33.5 ± 0.10 33.5 ± 0.19 32.2 ± 0.21 °°° 
A (control group), B (CCl4 group), C (standard drug group), D (200mg/kg plant) and E (400mg/kg plant). 
The difference was found to be significant (º P < 0.05   ºº P < 0.01 ººº P< 0.001) when compared with group B (CCl4 group), and significant (* P < 0.05 ** P < 0.01 
*** P < 0.001) when compared with group C (standard drug group).   
 
 
 Fig. (20) Histopathological changes in the livers of rats given water extract 
of Capparis decidua stems simultaneously with CCl4. 
 
 
(a) 
 
 
 
 
 
 
 
 
 
 
 
 
                              (b)                                                        (c) 
                                 (d)                                    (e) 
 
 
  
a)   Liver section (control group), showing normal histological appearance. H&E × 40.  
b) Liver section, standard drug group, showing mild hepatocyte vacuolation. H&E × 40. 
c) Liver section, CCl4 group, showing diffuse areas of vacuolar degeneration and 
centrilobular necrosis with mononuclear cell infiltration. H&E × 40. 
d) Liver section, rats treated with 200 mg/kg C. decidua: showing mild hepatocyte 
swelling. H&E × 40. 
e) Liver section, rats received 400 mg/kg C. decidua: showing mild vacuolar 
degeneration. H&E × 40.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3.2.1.4. Effect of Capparis decidua stems methanolic extract in 
CCl4 - induced liver damage in rats: 
The experimental design of the experiment is given in Table (12). 
 
3.2.1.4.1. Clinical finding:  
There where no observable clinical signs in all groups for the duration of the 
experiment except in CCl4 group B there were slight depression and loss of 
appetite. 
 
3.2.1.4.2. Post-mortem changes: 
In group B severe fatty changes, piteacheal haemorrhages and adhesions in all 
lobes of the liver were noticed.  
In group C (standard drug), there was slight fatty change and piteacheal 
haemorrhage.  
In group D (200 mg/kg) fatty changes and piteacheal haemorrhage were 
observed. In group E (400 mg/kg) no significant abnormalities were seen 
except slight congestion, piteacheal haemorrhages and slight fatty changes in 
the livers. 
 
3.2.1.4.3. Changes in serum constituent: 
These parameters are presented in Table (13), Figure (21), (22), (23) and (24).    
The increase of the serum AST, ALT, ALP and Bilirubin levels at day 5 and 10 
days after CCl4 administration was significantly (P < 0.01 – 0.001) reduced by 
treatment with methanolic extract of Capparis decidua stems at 200 mg/kg and 
400 mg/kg comparable with group B (CCl4 group) and (P < 0.05 - 0.01) when 
compared with group C (standard drug). 
 
 3.2.1.4.4. Haematological changes:-   
The mean value of Hb, PCV, MCV, RBCs and MCHC are given in Table (14). 
In CCl4 group there were significant decrease in the values of Hb, RBCs and 
MCHC (P < 0.01 - 0.001) and increase in MCV values (P< 0.001) when 
compared with group C.  
In group D there were significant increase in the values of Hb, RBCs and 
MCHC (P< 0.01 - 0.001) and significant decrease MCV values when compared 
with group B. 
In group E there were significant decrease in MCV values in day 5 (P< 0.01) 
and significant increase in day 10 (P< 0.05) comparable with group C and 
significant increase in the values of HB, RBC and MCHC (P< 0.01 - 0.001) 
and significant decrease MCV values (P< 0.001) when compared with group B.  
There were no significant changes in the control and standard drug groups. 
 
3.2.1.4.5. Histopathological changes: 
The results of histopathological changes are given in Fig. 25 (a - e).  
In group D (200 mg/kg) mild to moderate vacuolation were observed in 
hepatocytes. Distinct interlobular tissue and mononuclear cell infiltration in 
parenchyma and portal area. Most cells showed small vacuolation. 
In group E (400 mg/kg), mild to moderate vacuolar degeneration was observed 
with no definite pattern. Some hepatocytes exhibited cytoplasmolysis. Some 
hepatocytes also appeared swollen with small nuclei in size. 
There were lack of lobular pattern, areas of sinusoidal congestion and small 
aggregates of mononuclear cells in parenchyma. 
 
 
 
 
Table (12)                                                                                                              
Experimental design of rats given C. decidua stems methanolic extract 
simultaneously with CCl4.                                                                                    
 
Groups 
 
Animals 
No 
Doses Time of 
slaughtering 
Group A 
(Control) 
 
  
  
5 rats 
 
 
 
0.2 ml/kg liquid 
paraffin I/P 
 
 
10 days  
 
 
Group B 
(CCl4 
control) 
 
 
 
5 rats 
 
 
 
0.2 ml/kg CCl4 
in liquid paraffin (1:9)  
I/P 
 
 
10 days  
 
 
Group C 
Standard 
drug 
 
 
 
5 rats 
 
 
0.2 ml/kg CCl4 
in liquid paraffin (1:9) 
I/P + 100 mg/kg of 
silymarin in 5% acacia 
mucilage orally 
 
 
10 days  
 
 
Group D 
200 mg/kg    
C.decidua 
stems 
 
 
5 rats 
 
 
0.2 ml/kg CCl4 
in  liquid paraffin (1:9) 
I/P + 200 mg/kg of     
C. decidua stems     
methanolic extract 
orally 
 
 
10 days  
 
 
Group E 
400 mg/kg    
C. decidua 
stems 
 
 
 
5 rats 
 
 
0.2 ml/kg CCl4 
in liquid paraffin (1:9) 
I/P + 400 mg/kg of     
C. decidua stems   
methanolic extract 
orally 
 
 
10 days  
 
 
 
 
Table (13) Effect of C. decidua stems methanolic extract administered simultaneously with CCl4 on 
serum   constituents levels on rats:  
Bilirubin mg/dl (Mean ± S.E.) ALP U/I (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 0.21 ± 0.04 0.17 ± 0.03 °°° 
                    ** 
0.17 ± 0.02 °°° 
                  
403.1 ± 24.85 396.0 ± 65.94 °°° 402.0 ± 60.25 °°° 
B 0.22 ± 0.03      0.81 ± 0.03 
                   *** 
     1.04 ± 0.06 
                    *** 
398.1 ± 27.72    906.1 ± 35.73 
                      *** 
 1158.1 ± 58.43 
                       *** 
C 0.20 ±0.03      0.36 ± 0.04 °°° 0.28 ± 0.06 °°° 
 
486.5 ± 7.63 516.7 ± 16.35 °°° 537.1 ± 22.37 °°° 
D 0.26 ± 0.05      0.57 ± 0.06 °° 
                  * 
0.43 ± 0.05 °°° 
                   * 
420.0 ± 54.69 510.5 ± 82.86 °° 633.6 ± 4.02 °°° 
E 0.20 ± 0.03 0.49 ± 0.07 °° 0.27 ± 0.02 °°° 
 
408.2 ± 21.15 484.2 ± 67.23 °° 529.0 ± 47.08 °°° 
 
 
AST U/I (Mean ± S.E.) ALT U/I (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 35.2 ± 4.93 33.8 ± 3.87 °°° 
                   * 
33.8 ± 4.02 °°° 23.2 ± 5.50 25.2 ± 4.78 °°° 22.6 ± 4.41 °°° 
B 27.4 ± 2.64    188.2 ± 16.42 
                   *** 
   198.2 ± 18.78 
                    *** 
21.2 ± 3.51      89.2 ± 4.76 
                 *** 
   102.2 ± 7.42 
                      *** 
C 30.4 ± 1.54  48.6 ± 3.59 °°° 
 
42.4 ± 7.29 °°° 24.2 ± 4.41 29.2 ± 2.03 °°° 36.4 ± 3.40 °°° 
D 24.6 ± 3.74 55.4 ± 2.66 °°° 
 
63.4 ± 4.02 °°° 
                   * 
25.0 ± 1.41 54.0 ± 4.91 °° 
                    ** 
47.0 ± 2.28 °°° 
                    ** 
E 24.4 ± 3.40 45.6 ± 7.00 °°° 
 
41.2 ± 1.85 °°° 27.0 ± 6.01 37.2 ± 2.18 °°° 
                    * 
41.2 ± 1.85 °°° 
A (control group), B (CCl4 group), C (standard drug group), D (200 mg/kg plant) and E (400 mg/kg plant). 
The difference was found to be significant (º P < 0.05   ºº P < 0.01 ººº P< 0.001) when compared with group B (CCl4 group), and significant (* P < 0.05 ** P 
< 0.01 *** P < 0.001) when compared with group C (standard drug group).   
 
 
 Fig. (21) Effect of C. decidua stems methanolic extract administered 
simultaneously with CCl4 on serum bilirubin concentration on rats. 
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Fig. (22) Effect of C. decidua stems methanolic extract administered 
simultaneously with CCl4 on serum alkaline phosphatase levels on rats. 
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 Fig. (23) Effect of C. decidua stems methanolic extract administered 
simultaneously with CCl4 on AST levels on rats. 
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Fig. (24) Effect of C. decidua stems methanolic extract administered 
simultaneously with CCl4 on ALT levels on rats. 
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 Table (14) Effect of C. decidua stems methanolic extract administered simultaneously with CCl4 on 
haematological values on rats.  
Hb (g/dl) (Mean ± S.E.) PCV (%) (Mean ± S.E.) MCV (fl) (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 12.1 ± 2.13 11.4 ± 0.67 11.6 ± 0.81°° 34.2 ± 2.13 33.4 ± 1.69 33.6 ± 2.16 70.0 ± 1.80 73.7 ± 1.72 
                  * 
73.1± 1.61°°° 
 
B 11.8 ± 0.58 10.3 ± 0.30 8.0 ± 0.48  
                  ** 
33.0 ± 1.48 31.4 ± 1.63 33.4 ± 1.50 78.4 ± 1.53 87.2 ± 9.58 117.0±4.75 
                *** 
C 10.2 ± 0.63 10.3 ± 0.42 11.0 ± 0.60°° 31.0 ± 1.58 30.8 ± 1.28 32.4 ± 1.33 71.1 ± 5.33 84.9 ± 3.90 71.3± 2.51°°° 
 
D 10.5 ± 0.28 9.6 ± 1.02 11.3 ± 0.60°° 31.0 ± 0.71 30.6 ± 1.86 32.8 ± 1.62 74.3 ±2.15 73.0 ± 2.48 
                  * 
75.6± 2.76°°° 
 
E 10.4 ± 0.33 11.4 ± 0.99 11.9 ± 0.52°° 30.8 ± 1.07 34.2 ± 3.14 35.6 ± 0.51 75.7 ± 1.65 69.5 ± 1.07 
                 ** 
82.5± 3.20°°° 
                 * 
 
 
RBC (x 106) (Mean ± S.E.) MCHC (%) (Mean ± S.E.)  
Groups Day 0 Day 5 Day 10 Day 0 Day 5 Day 10 
A 4.87 ± 0.23 4.53 ± 0.18 
                      * 
4.60 ± 0.31°° 35.4 ± 0.52 34.2 ± 0.68 34.6 ± 0.78 °°° 
B 4.23 ± 0.26 3.81 ± 0.48 
 
      2.88 ± 0.17 
                   *** 
35.7 ± 1.04 33.1 ± 1.31      24.1 ± 0.56 
                    *** 
C 4.39 ± 0.11 3.66 ± 0.25 
 
4.54 ± 0.09 °°° 32.7 ± 0.51 33.3 ± 0.04 33.7 ± 0.59 °°° 
D 4.19 ± 0.22 4.20 ± 0.26 
 
4.38 ± 0.34 °° 33.9 ±0.34 32.5 ± 0.32 34.6 ± 0.49 °°° 
E 4.09 ± 0.22 4.88 ± 0.41 
                     * 
4.35 ± 0.19 °°° 33.8 ± 0.31 33.3 ± 0.16 32.9 ± 0.78 °°° 
A (control group), B (CCl4 group), C (standard drug group), D (200 mg/kg plant) and E (400 mg/kg plant). 
The difference was found to be significant (º P < 0.05   ºº P < 0.01 ººº P< 0.001) when compared with group B (CCl4 group), and significant (* P < 0.05 ** P < 
0.01 *** P < 0.001) when compared with group C (standard drug group).    
 
 
Fig. (25) Histopathological changes in the livers of rats given methanolic 
extract of Capparis decidua stems simultaneously with CCl4. 
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(b)                                                                          (c) 
  (d)                                                                            (e) 
 
 
a) Liver section (control group), showing normal histological appearance. H&E × 40. 
b) Liver section, standard drug group, showing mild hepatocyte vacuolation. H&E × 40. 
c) Liver section, CCl4 group, showing diffuse areas of vacuolar degeneration and 
centrilobular necrosis with mononuclear cell infiltration. H&E × 40. 
d) Section of 200 mg/kg C. decidua: showing vacuolar degeneration and mononuclear 
cell infiltration in parenchyma and portal areas. H&E × 40.  
e) Liver section of 400 mg/kg C. decidua: showing mild vacuolar degeneration and 
mild hepatocyte swelling. H&E × 40. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (15) Histopathological comparison between plants extracts under study against 
CCl4 induced liver damage in rats.  
 
Cellular infiltration  
Category 
 
Vacuolar 
degeneration 
 
Necrosis 
Portal  Parenchyma 
 
Remarks 
  
Control  
 
 
 
 
– 
 
 
– 
 
 
– 
 
 
– 
Congestion
 
 
CCl4 group 
 
 
+ + + ± 
 
 
+ + 
 
 
+ + ± 
 
 
+ + ± 
Centrilobular deg., 
bile duct 
proliferation, 
pyknosis,cytoplasmol
ysis and partial 
haemolysis.
 
 
Standard 
drug group 
 
 
+ ± 
 
 
– 
 
 
± 
 
 
± Peripheral vacuolar
deg., partial 
haemolysis
   
 
A1E 200 
 
 
 
 
 
± 
 
 
– 
 
 
± 
 
 
– Swelling , partial 
haemolysis
 
 
A1E 400 
 
 
 
 
 
+ ± 
 
 
– 
 
 
+ 
 
 
– 
Swelling, peripheral 
vacuolar deg., 
congestion.  
 
 
M1E 200 
 
 
 
 
 
+ + ± 
 
 
– 
 
 
+ + 
 
 
+ + 
 
Scattered vacuolar 
deg., congestion.
 
 
M1E 400 
 
 
 
 
+ +  
 
 
– 
 
 
+ 
 
 
 
 
 
± Swelling, scattered 
vacuolar deg. 
 
  
Keys: 
A1E 200 (aqueous extract of C. decidua 200 mg/kg), A1E 400(aqueous extract of C. decidua 
400 mg/kg), M1E 200(methanolic extract of C. decidua 200 mg/kg), M1E 400(methanolic 
extract of C. decidua 400 mg/kg), A2E 200(aqueous extract of D. glabra 200 mg/kg), A2E 
400(aqueous extract of D. glabra 400 mg/kg), M2E 200(methanolic extract of D. glabra 200 
mg/kg), M2E 400(methanolic extract of D. glabra 400 mg/kg).                                                 
 
 
 
 
 
 
 
 
 
 
A2E 200 
 
 
 
 
+ + +  
 
 
+ + ± 
 
 
 + + ± 
 
 
 + + ± 
Centrilobular deg., 
bile duct 
proliferation, 
pyknosis, 
cytoplasmolysis and 
partial haemolysis.
 
 
A2E 400 
 
 
 
 
+ + + ± 
 
 
+ + + ± 
 
 
+ + +  
 
 
+ + +  
Centrilobular deg., 
bile duct 
proliferation, 
pyknosis, 
cytoplasmolysis and 
partial haemolysis.
 
 
M2E 200 
 
 
 
 
+ + + ± 
 
 
+ + + ± 
 
 
+ + +  
 
 
+ + +  
Centrilobular deg., 
bile duct 
proliferation, 
pyknosis, 
cytoplasmolysis and 
partial haemolysis.
 
 
M2E 400 
 
 
 
 
+ + + + 
 
 
+ + + ± 
 
 
+ + +  
 
 
+ + +  
Diffuse vacuolar 
deg., bile duct 
proliferation, 
pyknosis, 
cytoplasmolysis and 
partial haemolysis.
3.2.2. Toxicity Experiments: 
The toxicity experiments were performed on water and methanolic extract of 
Capparis decidua stems.   
 
3.2.2.1. Toxicity experiment of Capparis decidua stems water 
extract in rats: 
The experimental design is shown in Table (16). 
 
3.2.2.1.1. Clinical signs: 
There where no obvious clinical signs in all groups all over the period of the 
experiment. 
 
3.2.2.1.2. Post mortem changes: 
There weren’t any abnormalities in the control group and group B except slight 
congestion. In group C (400 mg/kg) there were slight piteacheal haemorrhages.  
 
3.2.2.1.3. Serum constituents changes: 
These parameters are given in Table (17) Figures (26), (27), (28) and (29). 
There were no significant changes in the concentration of Bilirubin and in 
AST, ALT, and ALP level in the control group A. In the test group B (200 
mg/kg) there were a significant (P< 0.05) decrease in the mean values of ALP. 
In group C (400 mg/kg) there were significant (P< 0.05) increase in the values 
of ALT and a significant (P< 0.001) increase in AST levels when compared 
with group A.  
 
3.2.2.1.4. Haematological changes: 
The mean values of PCV, Hb, RBCs, MCV and MCHC are shown in Table 
(18). 
The mean values of these parameters fluctuate within the normal range during 
the period of investigation in the normal group (A) and tested groups (B-C). 
 
3.2.2.1.5. Histopathological finding:  
Histopathological sections of the experiment are presented in Figures (30), 
(31), (32), (33), (34), (35) and (36).  
No significant histopathological changes were seen in liver, kidney, spleen, 
intestine, stomach, lung or cardiac muscles in the control group.  
In kidney sections bowman’s space appeared to be wide, otherwise all tissue 
was normal.  
In the stomach no significant abnormalities were seen, however one area of 
lymphocytic infiltration was observed in the mucosa and also in sub epithelial 
layer and one focus in muscle layer.  
In intestine there was desquamation of epithelium of villi and the villi were 
widely separated from each other. Goblet cells were clearly seen.  
Lung sections showed congestion in the alveolar wall capillaries, areas of 
emphysema and presence of fibrin like materials in some alveoli. Collection of 
mononuclear cells around bronchioles and blood vessels and presence of large 
macrophages in alveoli were also observed. 
In group B (200 mg/kg C. deciduas water extract); no inflammatory or 
degenerative changes were seen in cardiac muscles. Muscles fibers appeared to 
be thin with appearance of spaces between them.    
In Liver sections there were slight sinusoidal dilatation, hepatocyte cytoplasm 
appeared granular and in many places were disintegrated giving irregular 
vacuolar appearance. Red blood cells appear to be empty.  
In Kidney section there was slight hypercellularity in the glomerular tuft and 
also many glomeruli showed distinct lobulations.    
In spleen sections white pulp was very distinct showing lymphoid hyperplasia 
and red pulp markedly congested.  
Stomach showed desquamation of the surface epithelium.    
In intestine showed long separated villi and normal intestinal glands and goblet 
cells activity. Lamina propria showed hypercellularity of mainly mononuclear 
cells.    
Lung sections showed congestion, areas of emphysema and foci of interstitial 
thickening (pneumonitis). Blood vessels contained haemolysed blood.   
In group C (400 mg/kg C. deciduas water extract); no inflammatory or 
degenerative changes  were seen in cardiac muscle except that muscle fibers 
appeared thin and separated from each other.  
Spleen section appears normal, lymphoid follicles well distinct and evenly 
distributed.  
Liver sections showed congestion, sinusoidal dilatation, partial haemolysis was 
observed in some vessels. Hepatocytes showed pyknosis and margination of 
chromatin. Granular degeneration and cytoplasmolysis was also seen.  
Kidney sections showed congestion, glomeruli appeared more loubulated and 
medullary tubules slightly dilated.   
In the stomach no significant changes were seen.  
In intestinal sections increased cellulareity in the laminar propria and one area 
of submucosal lymphoid tissue proliferation were seen.   
Lung sections showed many areas of interstitial thickening, congestion and 
small areas of emphysema. Haemolysed blood was seen in blood vessels.  
 
 
 
 
  
 
 
  
                                                                                                              )16 (Table   
Experimental design of rats dosed with C. decidua stems water extract.        
 
Groups Animals 
No 
Doses Time of 
slaughtering 
 
Group A 
(Control) 
 
  
5 rats 
 
 
 
 
Volume of distilled 
water 
 
 
21 days 
Group B 
(200 mg/kg C. 
decidua stem) 
 
 
5 rats 
 
 
200 mg/kg          
C. decidua stems 
water extract in 
distilled water orally
 
 
21 days 
 
Group C 
(400 mg/kg C. 
decidua stems) 
 
 
5 rats 
 
 
400 mg/kg          
C. decidua stems  
water extract in 
distilled water orally
 
 
21 days 
 
 
 
 
 
 
 
 
 
Table (17) 
Change in serum constituents values in rats treated with C. decidua stems water extract.    
 
Bilirubin mg/dl (Mean ±S.E.) 
 
ALP U/I (Mean ± S.E.) 
 
Groups 
Day 0 Day 21 Day 0 Day 21 
A 0.20 ± 0.02 
 
0.16 ± 0.01 427.8 ± 30.71 396.0 ± 43.32 
B 0.29 ± 0.02 
 
0.17 ± 0.00 416.4 ± 63.4 285.4 ± 11.43 * 
C 0.23 ± 0.05 
 
0.17 ± 0.02 442.0 ± 53.27 426.8 ± 17.86 
 
 
 
 
AST U/I (Mean±S.E.) 
 
ALT U/I (Mean±S.E.) 
 
Groups 
Day 0 Day 21 Day 0 Day 21 
A 166.0 ± 7.65 
 
111.2 ± 6.94 43.8 ± 3.43               24.6 ± 2.14 
B 148.0 ± 3.42 
 
119.2 ± 14.70 43.4 ± 4.43 33.0 ± 2.61 * 
C 175.2 ± 51.48 
 
    170.4 ± 7.43 ** 50.6 ± 11.13 35.8 ± 3.43 * 
A (control group), B (200 mg/kg plant), C (400 mg/kg plant). 
The difference was found to be significant (* P < 0.05   ** P < 0.001) when compared with group A (control group).  
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Fig. (26) Change in serum bilirubin concentrations in rats dosed with            
C. decidua stems water extract. 
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Fig. (27) Change in serum alkaline phosphatase in rats dosed with                
C. decidua stems water extract. 
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   Fig. (28) Change in AST activity in rats dosed with                                        
C. decidua stems water extract. 
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Fig. (29) Change in ALT activity in rats dosed with                                         
C. decidua stems water extract. 
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Table (18)  
Change in haematological values in rats treated with C. decidua stems water extract.   
 
 
Hb (g/dl) (Mean ± S.E.) 
 
PCV (%) (Mean ± S.E.) 
 
MCV (fl) (Mean ± S.E.) 
 
Groups 
Day 0 Day 21 Day 0 Day 21 Day 0 Day 21 
A 10..5 ± 0.23  11.3 ± 0.32 
 
30.8 ± 0.58 32.8 ± 0.66 70.4 ± 2.47 71.5 ± 2.83 
B 10.5 ± 0.17 11.4 ± 0.50 
 
31.2 ± 0.58 33.2 ± 1.53 73.9 ± 0.89 70.8 ± 1.22 
C 10.3 ± 0.20 12.1 ± 0.76 
 
30.8 ± 0.58 35.4 ± 1.50 74.0 ± 0.81 75.5 ± 0.33 
 
 
 
 
RBC (×106) (Mean ± S.E.) 
 
MCHC (%) (Mean ± S.E.) 
 
Groups 
Day 0 Day 21 Day 0 Day 21 
A 4.51 ± 0.21 4.47 ± 0.17 
 
34.1 ± 0.30 34.3 ± 0.32 
B 4.22 ± 0.09 4.70 ± 0.25 
 
33.8 ± 0.15 34.0 ± 0.38 
C 4.17 ± 0.10 4.69 ± 0.19 
 
33.5 ± 0.10 34.1 ± 0.78 
A (control group), B (200 mg/kg plant), C (400 mg/kg plant) 
  
 
 
 
 
 
  
Fig. (30)      Histopathological changes in the hearts of rats dosed with water 
extract of C. decidua stems. 
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(b) 
 
 
 
 
 
 
 
 
a)  Heart section, rats dosed with 200 mg/kg C. decidua showing: thining and separation cardiac muscles.  
             H & E × 100.                            
b)  Heart section, rats dosed with 400 mg/kg C. decidua showing: thining and separation cardiac muscles.  
             H & E × 100.                            
 
Fig. (31) Histopathological changes in the livers of rats dosed with water 
extract of C. decidua stems (H&E × 100). 
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(b) 
 
 
 
 
 
 
 
 
 
 
 
 
(c)  
 
 
 
 
a) Liver section: control group showing normal histological appearance. H & E × 100.                                         
b) Liver section: rats dosed with 200 mg/kg C. decidua showing granular hepatocytes cytoplasm and slight 
sinusoidal dilatation. H & E × 100.                                                                                                                      
c) Liver section: rats dosed with 400 mg/kg C. decidua showing granular degeneration, pyknosis, 
cytoplasmolysis      and sinusoidal dilatation. H & E × 100.                                                                               
Fig. (32) Histopathological changes in the livers of rats dosed with water 
extract of C. decidua stems (H&E × 250). 
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(b) 
 
 
 
 
 
 
 
 
 
 
(c) 
 
 
 
 
 
 
a)  Liver section: control group showing normal histological appearance. H & E × 250.      
b) Liver section: rats dosed with 200 mg/kg C. decidua showing granular hepatocytes cytoplasm and                  
slight sinusoidal dilatation. H & E × 250.                                                                                                          
c) Liver section: rats dosed with 400 mg/kg C. decidua showing granular degeneration, pyknosis,    
cytoplasmolysis and sinusoidal dilatation. H & E × 250.                                                                                    
Fig. (33) Histopathological changes in the livers of rats dosed with water 
extract of C. decidua stems (H&E × 500). 
 
 
 
 
 
 
 
(a) 
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(c)  
 
 
 
 
 
 
a)   Liver section: control group showing normal histological appearance. H & E × 500.                                       
b)  Liver section: rats dosed with 200 mg/kg C. decidua showing granular hepatocytes cytoplasm and slight            
sinusoidal dilatation. H & E × 500.                                                                                                                     
c) Liver section: rats dosed with 400 mg/kg C. decidua showing granular degeneration, pyknosis,                            
cytoplasmolysis and sinusoidal dilatation. H & E × 500.                                                                                                                    
Fig. (34) Histopathological changes in the kidneys of rats dosed with water 
extract of C. decidua stems (H&E × 100). 
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(b) 
 
 
 
 
 
 
 
 
 
 
 
(c) 
 
 
 
 
 
 a)  Section of kidney: rats dosed with 200 mg/kg C. decidua showing slight hypercellularity and lobulations in        
the glomerular tufts. H & E × 100.                            
 b) Section of kidney: rats dosed with 400 mg/kg C. decidua showing hypercellularity, lobulation of glomeruli        
tufts and slight widening of the medullary tubules. H & E × 100.                            
c) Section of kidney: normal group, showing normal histopathological pattern. H & E × 100.                                  
Fig. (35) Histopathological changes in the spleens of rats dosed with water 
extract of C. decidua stems. 
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(c) 
 
 
  
 
 
 
 
a) Spleen section, rats dosed with 200 mg/kg C. decidua showing lymphoid hyperplasia and marked                       
congestion of the red pulp. H & E × 100.                                                                                                            
b) Spleen section, rats dosed with 200 mg/kg C. decidua showing lymphoid hyperplasia and marked                       
congestion of the red pulp. H & E × 250.                                                                                                             
c)  Spleen section, rats dosed with 400 mg/kg C. decidua showing no histopathological changes. H & E × 250.                               
Fig. (36) Histopathological changes in the lungs of rats dosed with water 
extract of C. decidua stems (H&E × 100). 
 
 
 
 
 
 
(a) 
 
 
 
 
 
 
 
 
 
  
(b) 
 
 
 
 
 
 
 
 
 
 
 
(c) 
 
  
 
 
    a) Section of lung: control rats showing areas of emphysema and congestion. H & E × 100.     
    b) Section of lung: rats dosed with 200 mg/kg C. decidua showing foci of interstitial thickening, congestion           
and areas of emphysema. H & E × 100.                                                                                                           
    c) Section of lung: rats dosed with 400 mg/kg C. decidua showing areas of interstitial       thickening and                
small areas of emphysema. H & E × 250.                                                                                                                          
3.2.2.2. Toxicity experiment of Capparis decidua stems 
methanolic extract in rats: 
The experimental design doses and times of slaughtering are shown in Table 
(19). 
 
3.2.2.2.1. Clinical signs: 
There were no obvious clinical signs in all groups throughout the period of the 
experiment. 
 
3.2.2.2.2. Post mortem changes: 
In group B (200 mg/kg) there were slight piteacheal haemorrhages. In group C 
(400 mg/kg) slight congestion and slight fatty change were seen in the livers. 
There weren’t any abnormalities in the control group except slight congestion. 
 
3.2.2.2.3. Serum constituents changes: 
These parameters are given in Table (20) Figures (37), (38), (39) and (40).  
There were no significant changes in the concentration of Bilirubin and in 
AST, ALT, and ALP level in the control group and in the test group B (200 
mg/kg). In group C (400 mg/kg) there were significant increases (P < 0.05) in 
Bilirubin concentration and AST level when compared with control group A.  
 
3.2.2.2.4. Haematological changes: 
The mean values of PCV, Hb, RBCs, MCV and MCHC are shown in Table 
(21). 
There were significant (P < 0.05) increases in the mean values of Hb, PCV in 
group B (200 mg/kg). In group C (400 mg/kg) there were significant (P< 0.05 -
0.01) increase in the mean values of PCV and MCV, and significant (P< 0.05) 
decrease in the mean values of MCHC than the control group A. 
  
 
 
Table (19) 
Experimental design of rats dosed with C. decidua stems methanolic 
extract.                                                                                                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Groups Animals 
No 
Doses Time of 
slaughtering 
 
Group A 
(Control) 
 
 
5 rats 
  
 
 
 
Volume of distilled 
water 
 
 
21 days 
Group B 
(200 mg/kg 
C. decidua 
stem) 
 
 
5 rats 
 
 
200 mg/kg          
C. decidua stems 
methanolic extract in 
distilled water orally
 
 
21 days 
 
Group C 
(400 mg/kg    
C. decidua 
stems) 
 
 
5 rats 
 
 
400 mg/kg          
C. decidua stems 
methanolic extract in 
distilled water orally
 
 
21 days 
 
Table (20)  
Change in serum constituents values in rats treated with C. decidua stems methanolic extract.    
 
Bilirubin mg/dl (Mean ±S.E.) 
 
ALP U/I (Mean ± S.E.) 
 
Groups 
Day 0 Day 21 Day 0 Day 21 
A 0.16 ± 0.02 
 
0.15 ± 0.02 474.6 ± 31.33 450.4 ± 30.50 
B 0.19 ± 0.02 
 
0.21 ± 0.03 482.8 ± 7.27 439.2 ± 45.76 
C 0.18 ± 0.02 
 
  0.32 ± 0.03 * 447.6 ± 35.50 502.8 ± 25.92 
 
 
 
 
AST U/I (Mean±S.E.) 
 
ALT U/I (Mean±S.E.) 
 
Groups 
Day 0 Day 21 Day 0 Day 21 
A 122.0 ± 4.85 
 
117.8 ± 4.89 46.4 ± 2.14 48.4 ± 2.32 
B 167.2 ± 24.57 
 
148.0 ± 20.99 48.4 ± 4.26 50.0 ± 3.71 
C 112.4 ± 3.36 
 
 207.4 ± 23.24 * 40.2 ± 1.66 52.6 ± 4.15 
A (control group), B (200 mg/kg plant), C (400 mg/kg plant). 
The difference was found to be significant (* P < 0.05) when compared with group A (control group).  
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Fig. (37) Change in serum bilirubin concentrations in rats dosed with           
C. decidua stems methanolic extract. 
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Fig. (38) Change in serum alkaline phosphatase in rats dosed with                      
C. decidua stems methanolic extract. 
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    Fig. (39) Change in AST activity in rats dosed with                                        
C. decidua stems methanolic extract. 
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 Fig. (40) Change in ALT activity in rats dosed with                                        
C. decidua stems methanolic extract. 
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Table (21) 
Change in haematological values in rats treated with C. decidua stems methanolic extract.  
 
Hb (g/dl) (Mean ± S.E.) 
 
PCV (%) (Mean ± S.E.) 
 
MCV (fl) (Mean ± S.E.) 
 
Groups 
Day 0 Day 21 Day 0 Day 21 Day 0 Day 21 
A 10.8 ± 0.19 11.5 ± 0.22 
 
32.3 ± 0.61 34.7 ± 0.70 59.5 ± 0.93 56.5 ± 0.46 
B 10.7 ± 0.08    12.3 ± 0.24 * 
 
32.0 ± 0.16    37.0 ± 0.57 * 60.0 ± 0.11 57.7 ± 0.86 
C 11.0 ± 0.12 12.2 ± 0.28 
 
32.8 ± 0.38    37.5 ± 0.90 * 59.2 ± 0.26     59.0 ± 0.51 ** 
 
 
 
 
RBC (×106) (Mean ± S.E.) 
 
MCHC (%) (Mean ± S.E.) 
 
Groups 
 Day 0 Day 21 Day 0 Day 21 
A 5.42 ± 0.12 
 
6.14 ± 0.10 33.6 ± 0.27 33.2 ± 0.07 
B 5.34 ± 0.03 
 
6.38 ± 0.13 33.3 ± 0.05 33.0 ± 0.19 
C 5.54 ± 0.06 
 
6.34 ± 0.14 33.4 ± 0.11     32.6 ± 0.25 * 
A (control group), B (200 mg/kg plant), C (400 mg/kg plant). 
The difference was found to be significant (* P < 0.05   ** P < 0.01) when compared with group A (control group). 
 
3.2.2.2.5. Histopathological finding: 
Histopathological sections of the experiment are presented in Figures (41), 
(42), (43), (44), (45) and (46).  
No Histopathological changes were seen in liver cells kidney, spleen, 
intestine, stomach, lung, or cardiac muscles sections in the control group.  
Some foci of mononuclear cell infiltration were observed in the liver 
parenchyma (these have been commonly seen in the liver tissues of normal 
rats).   
In some kidney sections Bowman’s space appears to be wide, otherwise all 
tissue was normal.  
In stomach sections showed no significant abnormalities. However some 
lymphocytic infiltration in one area in glandular mucosa and also in sub 
epithelium layer and one focus in muscle layer.  
In intestine there were desquamation of epithelium of villi and the villi were 
widely separated and Goblet cells clearly seen.  
Lung sections showed congestion of alveoli wall capillaries, areas of 
emphysema and presence of fibrin – like materials in some alveoli. 
Collection of mononuclear cells around bronchioles and blood vessels and 
presence of large macrophages in alveoli were also observed. 
In group B (200 mg/kg C. deciduas methanolic extract) no significant 
changes were seen in cardiac muscles.  
Liver sections were almost normal except that hepatocyte cytoplasm 
appeared granular (condensation with out vacuoles); cells appear to be 
closely attached to each other (swelling). 
Kidney sections were almost normal. Glomerular tufts appeared to be 
lobulated and Bowman’s space narrowed. 
In the spleen the white pulp was not prominent. The sizes of follicles 
appeared normal but the distribution of lymphocytes was scattered and not 
compact.  
Stomach sections showed desquamation of the surface mucosa.  
In intestine showed submucosal lymphocytic nodules, dilation in mucosa 
and it appeared to be low. Villous structure was not intact only, intestinal 
glands appeared normal. 
The lungs showed emphysema, congestion, areas of interstitial thickening 
with mononuclear cell infiltration in alveoli and around small blood vessels.  
In group C (400 mg/kg C. deciduas methanolic extract), no significant 
abnormalities were seen in cardiac muscle except that the muscle fibers 
appeared to be separated from each other.  
Spleen section appears normal, lymphoid follicles (white pulp) more 
compact and more defined and distinct.  
In the liver dilation of central veins and portal veins was noticed. Some cells 
appeared to be compressed. Disassociation and fragmentation of hepatocytes 
were seen. Dilation of the hepatic sinusoids appears as clearly empty spaces 
between hepatic cords. There was one area of cellular infiltration. Vacuolar 
degeneration and in some areas complete disappearance of hepatocytes were 
also seen.  
Kidney sections showed congestion, segmentation and occasionally 
shrinkage of glomerular tufts. Some sections showed disintegrated tubular 
lining cells.  
In stomach sections of gastric gland appeared separated from each other, 
parietal cells seem to be prominent (numerous). Swelling of cells in the non 
glandular part was also noticed.  
In the intestine, the intestinal mucosa was not intact and dissociated. Cells of 
the intestinal glands were detached from the basement membranes.  
Lung sections showed areas of alveolar emphysema, dilated bronchioles, 
congestion of blood vessels and small areas of interstitial thickening.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig. (41) Histopathological changes in the livers of rats dosed with  
methanolic extract of C. decidua stems (H&E × 100). 
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a)  Liver section: control group, showing normal histological appearance. H & E × 100.                                       
b) Liver section: rats dosed with 200 mg/kg C. decidua showing granular cytoplasm and hepatocyte 
swelling.        H & E × 100.                                    
c) Liver section: rats dosed with 400 mg/kg C. decidua showing dilation of the hepatic sinusoids and 
central          veins and vacuolar degeneration. H & E × 100. 
Fig. (42) Histopathological changes in the livers of rats dosed with 
methanolic extract of C. decidua stems (H&E × 250). 
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a)  Liver section: control group, showing normal histological appearance. H & E × 250.             
 b) Liver section: rats dosed with 200 mg/kg C. decidua showing granular cytoplasm and hepatocyte 
swelling. 
     H & E × 250.                                    
c) Liver section: rats dosed with 400 mg/kg C. decidua showing dilation of the hepatic sinusoids and 
central         veins and vacuolar degeneration. H & E × 250.                                    
Fig. (43) Histopathological changes in the livers of rats dosed with  
methanolic extract of C. decidua stems (H&E × 500). 
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a) Liver section: control group, showing normal histological appearance. H & E × 500.                   
 b) Liver section: rats dosed with 200 mg/kg C. decidua showing granular cytoplasm and hepatocyte 
swelling.   
     H & E × 500.                                    
 c) Liver section: rats dosed with 400 mg/kg C. decidua showing dilation of the hepatic sinusoids and 
central         veins and vacuolar degeneration. H & E × 500.                                    
 
 
 
 
Fig. (44) Histopathological changes in the kidneys of rats dosed with 
methanolic extract of C. decidua stems (H&E × 100). 
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a)  Section of kidney: normal group, showing normal histopathological pattern. H & E × 100.   
 b) Section of kidney: rats dosed with 400 mg/kg C. decidua showing segmentations and shrinkage of                     
glomeruli tufts. H & E × 100.                                   
 
 
 
Fig. (45) Histopathological changes in the spleens of rats dosed with 
methanolic extract of C. decidua stems (H&E × 100). 
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a)  Spleen section, normal rats, showing normal histopathological appearance.  H & E × 110.  
b)  Spleen section, rats dosed with 200 mg/kg C. decidua showing normal size of white pulp with loosely               
arranged lymphocytes (not compact). H & E × 100.                                                                                            
c)  Spleen section, rats dosed with 400 mg/kg C. decidua showing no histopathological changes. H & E × 
110. 
Fig. (46) Histopathological changes in the lungs of rats dosed with 
methanolic extract of C. decidua stems (H&E × 100). 
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a)  Section of lung: control rats showing areas of emphysema and congestion. H & E × 100.       
b) Section of lung: rats dosed with 200 mg/kg C. decidua showing emphysema, areas of interstitial 
thickening       with mononuclear cell infiltration in alveoli and around small vessels.  H & E × 100.                                       
 c) Section of lung: rats dosed with 400 mg/kg C. decidua showing alveolar emphysema, dilated 
bronchioles           areas of interstitial thickening. H & E × 110.                                                                                                           
DISSCUSSION 
 
The present work has been an attempt to elucidate likely hepatoprotective    
properties of some indigenous plants commonly reputed to attain these ends.      
Inadequacy of treatment with conventional drugs and possible hazards 
associated with their use prompted our search for better and safer 
hepatoprotectives of herbal origin. Ozbec et al, (2004) have proposed similar 
lines of investigation. Our choice of the tow plants has been based on the 
widely held folkloric belief that these plants possess effectivity against 
jaundice and they are component of many polyherbal formulations 
(ELGhaza et al, 1987 ; ELKamali et al, 1999).                                                                       
As determination of serum levels of enzymes such as SGOT and SGPT 
renders a reliable means of assessment of liver damage (Gupta et al, 2004).  
Our results using the model of CCl4 – induced hepatotoxicity in rats 
demonstrated that Dobera glabra leaves (200 – 400 mg/kg), unlike silymarin 
caused significant elevation of AST, ALT, ALP as well as bilirubin 
concentration. However, severe necrotic hepatic lesions precipitated by CCl4 
were not reduced by neither the aqueous nor methanolic extract of the plant 
leaves.                                                                                                                     
Both extracts, aqueous and methanolic, from Capparis decidua stems 
reduced the levels of AST, ALT, ALP and bilirubin when given prior to 
CCl4 intoxication. This suggests hepatoprotective activity endowed in this 
plant. Further supportive evidence to this suggestion in rendered by the 
observation that the necrotic lesions were also reduced by both extracts plus 
the haematological findings. All observations are indicative of 
hepatoprotective properties of the extracts.                                                                                 
Furthermore, the present study revealed evidence of the existence of 
flavonoids, cyanogenic glucosides and triterpenoid in agreement with the 
findings of previous workers (ALYahya, 1986 ; Evans, 2002), probably due 
to antioxidant properties (Gupta et al, 2004), of this plant. This may well by 
responsible for the protective ability against CCl4 liver damage in rats. In 
this respect, previous studies also showed that other species of the genus 
Capparis e.g. C. spinosa have potential protective activity against liver 
damage (Gadogli and Mishra 1995).                                                                                            
Our results have also shown appreciably high contents, in the plant, of 
minerals e.g. Fe2+ and vitamins e.g. vit C which may contribute to the 
extracts hepatoprotectivity as also suggested by Duhan et al, (1992). The 
role of vit C in protecting liver damage may be attributed to the l-isomer of 
ascorbic acid and dehydroascorbic acid. This reversible oxidation – 
reduction process accounts for the ability of vit C to act as an antioxidant in 
biological systems. That the enzymatic hydroxylation of proline and lysine 
during collagen synthesis requires ascorbic acid probably to protect the 
hydroxylase enzymes from oxidative damage by Fe2+ and mixed sulphides. 
This may be also involve other oxidative reactions such as these catalyzed 
by ascorbic acid oxidase, cytochrome oxidase and peroxidase. Vit C can also 
hampers processes activity xenobiotics of harmful nature cased by mixed-
function oxidase (Adams, 2001). Probably C. decidua extracts exercise their 
hepatoprotective influence through reactions and interactions as postulated 
by Gupta et al, (2004) with respect to superoxide radicals generated using 
xanthine oxidase system. However, CCl4 hepatotoxicity depends on the 
reactive dehalogenation of CCl4 catalysed by Cyt 450 in the liver cells 
endoplasmic reticulum leading to the generation of an unstable complex  
CCl•3 radical, which is reported as a highly reactive species. These free 
radical attack microsomal lipids leading to its peroxidation and also 
covalently bind to microsomal lipids and proteins ultimately initiating a site 
of secondary biochemical processes which is the ultimate cause for the 
unfolding of the panorama of pathological consequences of CCl4 
metabolism.                   Long term administration of high doses of both 
extracts (aqueous and methanol) showed hepatotoxic effects indicated by the 
elevated, AST, ALT, ALP levels and bilirubin concentration and the 
histopathological changes in hepatocytes, probably due to effect of 
cyanogenic glycoside (Clarke et al, 1981), though no mortality was 
observed. These findings indicate that the hepatotoxic effect of the plant is 
more expressed in animals receiving high doses of the extraction for longer 
periods.                                                             
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Conclusions and Recommendations  
 
1. These observations might lend credibility to the use of Capparis 
decidua stems in the traditional system of medicine in Sudan to curb 
the progress of jaundice.    
2. Both aqueous and methanolic extracts of the stems of the plant 
Capparis decidua contain hepatoprotective ingredient(s) that protect 
from carbon tetrachloride induced hepatic damage. The activity of the 
tested samples was comparable to that of silymarin used as a reference 
drug.    
3. Moreover, our results show that the aqueous extract of C.decidua has 
higher activity than the methanolic extract, probably related to the 
more polar phytoconstituents. 
4. What component(s) of the extract is responsible for this effect, 
however, was not investigated, but could be related to its free radical 
scavenging properties or antioxidant properties. 
5. Further investigation may have to be done to determine the exact 
phytoconstituents(s) responsible for hepatoprotective effects.  
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